SentinelOne (S) 10-K 7 Apr 22 2022 FY Annual report Financial data

Cover

Cover - USD ($) $ in Billions	12 Months Ended
	Jan. 31, 2022	Mar. 31, 2022	Jul. 31, 2021
Entity Information [Line Items]
Document Type	10-K
Document Anual Report	true
Document Period End Date	Jan. 31, 2022
Current Fiscal Year End Date	--01-31
Document Transition Report	false
Entity File Number	001-40531
Entity Registrant Name	SENTINELONE, INC
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	99-0385461
Entity Address, Address Line One	444 Castro Street, Suite 400
Entity Address, City or Town	Mountain View
Entity Address, State or Province	CA
Entity Address, Postal Zip Code	94041
City Area Code	855
Local Phone Number	868-3733
Title of 12(b) Security	Class A common stock, par value $0.0001
Trading Symbol	S
Security Exchange Name	NYSE
Entity Well-known Seasoned Issuer	No
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Public Float			$ 6.9
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	FY
Amendment Flag	false
Entity Central Index Key	0001583708
Class A Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		185,652,297
Class B Common Stock
Entity Information [Line Items]
Entity Common Stock, Shares Outstanding (in shares)		86,103,088

Audit Information

Audit Information	12 Months Ended
	Jan. 31, 2022
Audit Information [Abstract]
Auditor Name	DELOITTE & TOUCHE LLP
Auditor Location	San Jose, California
Auditor Firm ID	34

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021
Current assets:
Cash and cash equivalents	$ 1,669,304	$ 395,472
Short-term investments	374	364
Accounts receivable, net	101,491	39,315
Deferred contract acquisition costs, current	27,546	14,733
Prepaid expenses and other current assets	18,939	14,173
Total current assets	1,817,654	464,057
Property and equipment, net	24,918	13,373
Operating lease right-of-use assets	23,884	18,026
Deferred contract acquisition costs, non-current	41,022	21,940
Intangible assets, net	15,807	470
Goodwill	108,193	0
Other assets	10,703	2,694
Total assets	2,042,181	520,560
Current liabilities:
Accounts payable	9,944	11,822
Accrued liabilities	22,657	3,671
Accrued payroll and benefits	61,150	20,134
Operating lease liabilities, current	4,613	3,634
Deferred revenue, current	182,957	89,645
Total current liabilities	281,321	128,906
Deferred revenue, non-current	79,062	52,190
Long-term debt	0	19,621
Operating lease liabilities, non-current	24,467	18,839
Other liabilities	6,543	401
Total liabilities	391,393	219,957
Commitments and contingencies
Redeemable convertible preferred stock; $0.0001 par value; zero and 168,985,413 shares authorized as of January 31, 2022 and 2021, respectively; zero and 167,058,113 shares issued and outstanding as of January 31, 2022 and 2021, respectively, and liquidation preference of zero and $622,414 as of January 31, 2022 and 2021, respectively	0	621,139
Stockholders’ equity (deficit):
Preferred stock; $0.0001 par value; 50,000,000 and zero shares authorized as of January 31, 2022 and 2021, respectively; and zero shares issued and outstanding as of January 31, 2022 and 2021	0	0
Additional paid-in capital	2,271,980	29,869
Accumulated other comprehensive income	454	165
Accumulated deficit	(621,673)	(350,572)
Total stockholders’ equity (deficit)	1,650,788	(320,536)
Total liabilities, redeemable convertible preferred stock, and stockholders’ equity (deficit)	2,042,181	520,560
Class A Common Stock
Stockholders’ equity (deficit):
Common stock, value, issued	16	0
Class B Common Stock
Stockholders’ equity (deficit):
Common stock, value, issued	$ 11	$ 2

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021
Redeemable convertible preferred stock, par value (in USD per share)	$ 0.0001	$ 0.0001
Redeemable convertible preferred stock, shares authorized (in shares)	0	168,985,413
Redeemable convertible preferred stock, shares outstanding (in shares)	0	167,058,113
Redeemable convertible preferred stock, shares issued (in shares)	0	167,058,113
Redeemable convertible preferred stock, liquidation amount	$ 0	$ 622,414
Preferred stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Preferred stock, shares authorized (in shares)	50,000,000	0
Preferred stock, shares issued (in shares)	0	0
Preferred stock, shares outstanding (in shares)	0	0
Class A Common Stock
Common stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	1,500,000,000	0
Common stock, shares, issued (in shares)	162,666,515	0
Common stock, shares, outstanding (in shares)	162,666,515	0
Class B Common Stock
Common stock, par or stated value per share (in USD per share)	$ 0.0001	$ 0.0001
Common stock, shares authorized (in shares)	300,000,000	264,659,000
Common stock, shares, issued (in shares)	107,785,100	39,242,316
Common stock, shares, outstanding (in shares)	107,785,100	39,242,316

Consolidated Statements of Oper

Consolidated Statements of Operations - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Income Statement [Abstract]
Revenue	$ 204,799	$ 93,056	$ 46,474
Cost of revenue	81,677	39,332	18,331
Gross profit	123,122	53,724	28,143
Operating expenses:
Research and development	136,274	62,444	36,683
Sales and marketing	160,576	77,740	51,322
General and administrative	93,504	29,059	15,122
Total operating expenses	390,354	169,243	103,127
Loss from operations	(267,232)	(115,519)	(74,984)
Interest income	202	231	886
Interest expense	(787)	(1,401)	(2,015)
Other income (expense), net	(2,280)	(424)	(217)
Loss before provision for income taxes	(270,097)	(117,113)	(76,330)
Provision for income taxes	1,004	460	237
Net loss	$ (271,101)	$ (117,573)	$ (76,567)
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share)	$ (1.56)	$ (3.31)	$ (2.34)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share)	$ (1.56)	$ (3.31)	$ (2.34)
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	174,051,203	35,482,444	32,712,350
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	174,051,203	35,482,444	32,712,350

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Statement of Comprehensive Income [Abstract]
Net loss	$ (271,101)	$ (117,573)	$ (76,567)
Other comprehensive income (loss):
Foreign currency translation adjustments	289	366	(378)
Total comprehensive loss	$ (270,812)	$ (117,207)	$ (76,945)

Consolidated Statements of Rede

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)	Total	Series D	Series E	Series F	Common StockClass A and Class B Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Accumulated Deficit
Shares, beginning of period (in shares) at Jan. 31, 2019	97,686,390
Balance, beginning of period at Jan. 31, 2019	$ 149,955,000
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Preferred Stock, net of issuance costs (in shares)		15,837,558
Issuance of Preferred Stock, net of issuance costs		$ 51,871,000
Shares, end of period (in shares) at Jan. 31, 2020	113,523,948
Balance, end of period at Jan. 31, 2020	$ 201,826,000
Shares, beginning of period (in shares) at Jan. 31, 2019					31,679,835
Balance, beginning of period at Jan. 31, 2019	(152,594,000)				$ 1,000	$ 3,660,000	$ 177,000	$ (156,432,000)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)					1,870,974
Issuance of common stock upon exercise of options	899,000					899,000
Vesting of early exercised options	68,000					68,000
Stock based compensation expense	4,359,000					4,359,000
Foreign currency translation adjustments	(378,000)						(378,000)
Net loss	(76,567,000)							(76,567,000)
Shares, end of period (in shares) at Jan. 31, 2020					33,550,809
Balance, end of period at Jan. 31, 2020	$ (224,213,000)				$ 1,000	8,986,000	(201,000)	(232,999,000)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Preferred Stock, net of issuance costs (in shares)			31,405,183	22,128,982
Issuance of Preferred Stock, net of issuance costs			$ 152,539,000	$ 266,774,000
Shares, end of period (in shares) at Jan. 31, 2021	167,058,113	29,078,931	31,405,183	22,128,982
Balance, end of period at Jan. 31, 2021	$ 621,139,000	$ 95,239,000	$ 152,539,000	$ 266,774,000
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise of options (in shares)					5,358,692
Issuance of common stock upon exercise of options	4,608,000				$ 1,000	4,607,000
Issuance of common stock upon exercise of warrants (in shares)					321,802
Issuance of common stock upon exercise of warrants	200,000					200,000
Issuance of restricted stock for services provided (in shares)					11,013
Issuance of common stock for services provided	47,000					47,000
Vesting of early exercised options	71,000					71,000
Stock based compensation expense	15,958,000					15,958,000
Foreign currency translation adjustments	366,000						366,000
Net loss	(117,573,000)							(117,573,000)
Shares, end of period (in shares) at Jan. 31, 2021					39,242,316
Balance, end of period at Jan. 31, 2021	$ (320,536,000)				$ 2,000	29,869,000	165,000	(350,572,000)
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of Preferred Stock, net of issuance costs (in shares)			31,405,183	22,128,982
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	(167,058,113)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	$ (621,139,000)
Shares, end of period (in shares) at Jan. 31, 2022	0
Balance, end of period at Jan. 31, 2022	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)					169,787,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	621,139,000				$ 10,000	621,129,000
Issuance of common stock upon initial public offering and private placement, net of underwriting discounts and commissions (in shares)					41,678,568
Issuance of common stock upon initial public offering and private placements, net of underwriting discounts and commissions	1,380,960,000				$ 4,000	1,380,956,000
Issuance of common stock upon exercise of options (in shares)					9,793,331
Issuance of common stock upon exercise of options	14,621,000				$ 10,000	14,611,000
Issuance of common stock upon exercise of warrants (in shares)					940,953
Issuance of restricted stock for services provided (in shares)					20,000
Issuance of common stock for services provided	500,000					500,000
Vesting of restricted stock units (in shares)					15,218
Issuance of common stock under employee stock purchase plan (in shares)					381,716
Issuance of common stock under employee stock purchase plan	11,356,000					11,356,000
Vesting of early exercised options	572,000					572,000
Issuance of common stock and awards assumed in connection with acquisition (in shares)					7,277,214
Issuance of common stock and awards assumed in connection with Scalyr acquisition	120,320,000				$ 1,000	120,319,000
Issuance of restricted stock awards (in shares)					1,315,099
Stock based compensation expense	92,668,000					92,668,000
Foreign currency translation adjustments	289,000						289,000
Net loss	(271,101,000)
Shares, end of period (in shares) at Jan. 31, 2022					270,451,615
Balance, end of period at Jan. 31, 2022	$ 1,650,788,000				$ 27,000	$ 2,271,980,000	$ 454,000	$ (621,673,000)

Consolidated Statements of Re_2

Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) (Parenthetical) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2021	Jan. 31, 2020
Series D
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs		$ 0.1
Series E
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$ 0.1
Series F
Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs	$ 0.1

Condensed Consolidated Statemen

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
CASH FLOW FROM OPERATING ACTIVITIES:
Net loss	$ (271,101)	$ (117,573)	$ (76,567)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	7,909	2,837	1,855
Amortization of deferred contract acquisition costs	21,670	11,518	5,749
Non-cash operating lease costs	2,862	3,085	0
Stock-based compensation expense	87,889	15,912	4,346
Other	(456)	(22)	(35)
Changes in operating assets and liabilities, net of effects of acquisition
Accounts receivable	(59,082)	(8,320)	(18,986)
Prepaid expenses and other current assets	(7,319)	(9,438)	(1,237)
Deferred contract acquisition costs	(53,565)	(26,934)	(14,606)
Accounts payable	(2,076)	7,429	2,854
Accrued liabilities	18,080	1,374	643
Accrued payroll and benefits	41,462	7,758	5,644
Operating lease liabilities	(3,139)	(3,261)	0
Deferred revenue	115,142	49,065	46,264
Other liabilities	6,136	0	(348)
Net cash used in operating activities	(95,588)	(66,570)	(44,424)
CASH FLOW FROM INVESTING ACTIVITIES:
Purchases of property and equipment	(3,653)	(3,283)	(953)
Purchases of intangible assets	(802)	(224)	(200)
Capitalization of internal-use software	(5,839)	(2,758)	(1,700)
Purchases of strategic investments	(6,000)	0	(334)
Cash paid for acquisition, net of cash and restricted cash acquired	(3,449)	0	0
Net cash used in investing activities	(19,743)	(6,265)	(3,187)
CASH FLOW FROM FINANCING ACTIVITIES:
Proceeds from issuance of Series D redeemable convertible preferred stock, net of issuance costs	0	0	51,871
Proceeds from issuance of Series E redeemable convertible preferred stock, net of issuance costs	0	152,539	0
Proceeds from issuance of Series F redeemable convertible preferred stock, net of issuance costs	0	266,774	0
Payments of deferred offering costs	(7,416)	0	0
Proceeds from revolving line of credit	0	19,857	0
Repayment of debt	(20,000)	(20,000)	0
Proceeds from exercise of stock options	14,622	4,608	899
Proceeds from exercise of warrants	0	200	0
Proceeds from initial public offering and private placement, net of underwriting discounts and commissions	11,356	0	0
Proceeds from initial public offering and private placement, net of underwriting discounts and commissions	1,388,562	0	0
Net cash provided by financing activities	1,387,124	423,978	52,770
EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS	1,146	289	36
NET INCREASE IN CASH, CASH EQUIVALENTS, AND RESTRICTED CASH	1,272,939	351,432	5,195
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–Beginning of period	399,112	47,680	42,485
CASH, CASH EQUIVALENTS, AND RESTRICTED CASH–End of period	1,672,051	399,112	47,680
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION:
Interest paid	409	1,379	1,844
Income taxes paid, net	583	298	363
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:
Stock-based compensation capitalized as internal-use software	4,779	46	13
Property and equipment purchased but not yet paid	913	78	152
Vesting of early exercised stock options	575	71	68
Deferred offering costs accrued but not yet paid	186	0	0
Issuance of common stock and assumed equity awards in connection with acquisition	120,319	0	0
Conversion of redeemable convertible preferred stock to common stock upon initial public offering	$ 621,139	$ 0	$ 0

Organization and Description of

Organization and Description of Business	12 Months Ended
	Jan. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Organization and Description of Business	ORGANIZATION AND DESCRIPTION OF BUSINESS Business SentinelOne, Inc. (SentinelOne, we, our, or us) was incorporated in January 2013 in the State of Delaware. On March 29, 2021, we amended our certificate of incorporation to change our name from Sentinel Labs, Inc. to SentinelOne, Inc. We are a cybersecurity provider that delivers an artificial intelligence-powered platform to enable autonomous cybersecurity defense. Our headquarters is located in Mountain View, California with various other global office locations. Initial Public Offering and Private Placement In July 2021, we completed our initial public offering (IPO) and a concurrent private placement, in which we issued and sold an aggregate of 41,678,568 shares of our Class A common stock at $35 per share, including 5,250,000 shares issued upon the exercise of the underwriters’ option to purchase additional shares and 1,428,568 shares issued pursuant to the private placement. We received net proceeds of approximately $1.4 billion after deducting underwriting discounts, commissions and deferred offering costs.

Summary of Significant Accounti

Summary of Significant Accounting Policies	12 Months Ended
	Jan. 31, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of SentinelOne and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation. Fiscal Year Our fiscal year ends on January 31. References to fiscal 2022, 2021 and 2020 refer to the fiscal years ended January 31, 2022, January 31, 2021 and January 31, 2020, respectively. Forward Stock Split On February 6, 2020, we effected a one-to-three forward stock split of our issued and outstanding shares of common stock and redeemable convertible preferred stock. The par values of common stock and redeemable convertible preferred stock were not adjusted as a result of the stock split. All references to shares of common stock, options, warrants, and redeemable convertible preferred stock and per share amounts have been retroactively adjusted to reflect the forward stock split for the periods presented. Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates include, but are not limited to, the valuation of our common stock prior to our IPO in June 2021, stock-based compensation, the period of benefit for deferred contract acquisition costs, standalone selling prices (SSP) for each performance obligation, useful lives of long-lived assets, the incremental borrowing rate (IBR) used for operating lease liabilities, and accounting for income taxes. Actual results could differ from those estimates. As the impact of the COVID-19 pandemic continues to evolve, estimates and assumptions about future events and their effects cannot be determined with certainty and therefore require increased judgment. These estimates and assumptions may change in future periods and will be recognized in the consolidated financial statements as new events occur and additional information becomes known. To the extent our actual results differ materially from those estimates and assumptions, our future financial statements could be affected. Segment and Geographic Information We have a single operating and reportable segment. Our chief operating decision maker (CODM) is our Chief Executive Officer. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and assessing financial performance. For information regarding our revenue and long-lived assets by geography, see Notes 3 and 14, respectively. Foreign Currency During fiscal 2022, we changed the functional currency of certain subsidiaries from their respective local currency to the U.S. dollar. The change in functional currency is due to increased exposure to the U.S. dollar as a result of a change in facts and circumstances in the primary economic environment in which these subsidiaries operate. The effects of the change in functional currency were not significant to our consolidated financial statements. Subsequent to the change, our reporting currency and the functional currency of our foreign subsidiaries is the U.S. dollar. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations and were not material for any periods presented. Revenue Recognition We recognize revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. Revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration that we expect to be entitled to receive in exchange for the subscriptions and services. We apply the following five-step approach to recognize revenue: (i) Identification of the Contract, or Contracts, with the Customer —We determine that we have a contract with a customer when the contract is approved, the payment terms for the services can be identified, each party’s rights regarding the services to be transferred can be identified, the customer has the ability and intent to pay, and the contract has commercial substance. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information of the customer. We sell through our indirect relationships with our channel partners or direct relationships with end customers through our internal sales force. Apart from certain sales arrangements where channel partners are determined to be our customers, we have concluded that the end customer is our customer. (ii) Identification of the Performance Obligations in the Contract —Performance obligations in a contract are identified based on the services that will be transferred to a customer that are both capable of being distinct, where the customer can benefit from the service either on its own or together with other resources that are readily available to the customer, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, we apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised services are accounted for as a combined performance obligation. We have concluded that our contracts with customers do not contain warranties that give rise to a separate performance obligation. (iii) Determination of the Transaction Price —The transaction price is the amount of consideration we expect to be entitled from a customer in exchange for providing the subscriptions and services. Variable consideration is included in the transaction price if, in our judgment, it is probable that no significant future reversal of cumulative revenue under the contract will occur. Some of our end customers are entitled to receive service level commitment credits, in which we may be contractually obligated to provide partial refunds, and in rare instances, each representing a form of variable consideration. We have historically not experienced any significant incidents affecting the defined guarantees of performance levels or service response affecting the defined guarantees of performance levels or service response rates, and accordingly, estimated refunds related to service level commitment credits in the consolidated financial statements were not material during fiscal 2022, 2021 and 2020. None of our contracts contain a significant financing component. The transaction price excludes amounts collected on behalf of third parties, such as sales taxes. (iv) Allocation of the Transaction Price to the Performance Obligations in the Contract —If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on relative SSP. (v) Recognition of Revenue when, or as, Performance Obligations are Satisfied —Revenue is recognized when control of the related performance obligation is transferred to the customer in an amount that reflects the consideration expected to be received in exchange for the subscriptions or services. We generate substantially all of our revenue from subscriptions to our Singularity Platform. Our Singularity Platform delivers artificial intelligence-powered threat prevention, detection, and response capabilities, enabling an automatic protection against a full spectrum of cyber threats. We built our Singularity Platform to be deployed as a cloud service or in private and hybrid clouds. Customers can extend the functionality of their subscription to our platform by subscribing to additional Singularity Modules. The nature of our promise to the customer under the subscription is to stand ready to provide protection for the duration of the contractual term. As a result, we recognize revenue for these performance obligations ratably over the contractual term. Premium support and maintenance and other Singularity Modules are distinct from subscriptions and are recognized ratably over the term as the performance obligations are satisfied. We generally invoice our customers upfront upon signing for the entire term of the contract, periodically, or in arrears. Most of our subscription contracts have a term of one to three years. Our payment terms typically range between 30 to 45 days. The invoiced amounts are treated as deferred revenue on the consolidated balance sheets and are recognized ratably over the term of the contract beginning on the date the customer is given access to our platform. Our contracts are generally non-cancelable over the contractual term. Contracts with Multiple Performance Obligations Our contracts with customers may contain multiple promised services consisting of subscriptions to our Singularity Platform, premium support and maintenance, and other Singularity Modules that are distinct and accounted for separately. The transaction price is allocated to separate performance obligations on a relative SSP basis. Our best evidence for SSP is the price we charge for the subscription or service when we sell it separately in similar circumstances to similar customers. In instances where performance obligations do not have observable standalone sales, we utilize available information that may include, but is not limited to, product groupings or applying the expected cost-plus margin approach to estimate the price we would charge if the service was sold separately. Cost of Revenue Cost of revenue consists primarily of third-party cloud infrastructure expenses incurred in connection with the hosting and maintenance of our platform, personnel-related costs associated with our customer support and services organization, including salaries, benefits, bonuses, and stock-based compensation, amortization of capitalized internal-use software, software and subscription services used by our customer support and services team, and allocated overhead costs. Research and Development Research and development costs are expensed as incurred, unless they qualify for recognition as capitalized internal-use software. Research and development expenses consist primarily of personnel-related costs, including salaries, benefits, bonuses, and stock-based compensation, consulting fees, software and subscription services, third-party cloud infrastructure expenses incurred in developing our platform and modules, and allocated overhead costs. Advertising Expenses Advertising costs are expensed as incurred and included in sales and marketing expenses in the consolidated statements of operations. Advertising expenses were $7.8 million, $6.2 million, and $4.2 million, for fiscal 2022, 2021 and 2020, respectively. Stock-Based Compensation We account for stock-based awards issued to employees and directors based on the fair value of the awards at grant date. The fair value of stock option awards granted and rights to purchase shares under our employee stock purchase plan (ESPP) are generally estimated using the Black-Scholes option pricing model. Stock-based compensation expense for awards with only service-based vesting conditions is recognized on a straight-line basis over the requisite service period of the awards. Forfeitures are accounted for in the period in which they occur. We granted certain awards that have both a service-based and achievements of certain milestones. We recognize stock-based compensation expense on a graded basis over the total requisite service period for each separately vesting portion of the performance tranches related to these performance milestone options. We also granted stock option awards with a service-based, performance-based, and market-based vesting conditions to our Chief Executive Officer and Chief Financial Officer, These stock options will vest 100% upon the occurrence of our IPO (the performance-based vesting condition) and the achievement of certain milestone events and our share price targets (the market-based vesting conditions), subject to the executive’s continued service to us from the grant date through the milestone events. For these options, we used a Monte Carlo simulation to determine the fair value at the grant date and the implied service period. For these awards, stock-based compensation expense is recognized using the accelerated attribution method over the requisite implied service period when it is probable the performance-based vesting condition will be achieved. Income Taxes We are subject to income taxes in the United States and other foreign jurisdictions. We utilize the asset and liability method of accounting for income taxes whereby deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, as well as from net operating loss carryforwards, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. We consider all available evidence, both positive and negative, including historical levels of income, expectations, and risks associated with estimates of future taxable income in assessing the need for a valuation allowance. We recognize income tax benefits from uncertain tax positions only if we believe that it is more likely than not that the tax position will be sustained upon examination by the taxing authorities based on the technical merits of the position. We recognize penalties and accrued interest related to unrecognized tax benefits as a component of other income (expense), net and interest expense, respectively, in the consolidated statements of operations. Net Loss per Share Attributable to Common Stockholders We compute basic and diluted net loss per share attributable to common stockholders using the two-class method required for participating securities. We consider our redeemable convertible preferred stock, restricted common stock, and shares issued upon the early exercise of stock options subject to repurchase to be participating securities. Under the two-class method, net loss is not allocated to redeemable convertible preferred stock, restricted common stock, and early exercised stock options as the holders do not have a contractual obligation to share in our losses. Cash, Cash Equivalents, and Restricted Cash We consider all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of amounts invested in money market funds. Restricted cash consists of collateralized letters of credit established in connection with lease agreements for our office facilities. Restricted cash, current and non-current, are included within prepaid expenses and other current assets and other assets, respectively, on our consolidated balance sheets. The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the consolidated statements of cash flows (in thousands): As of January 31, 2022 2021 Cash and cash equivalents $ 1,669,304 $ 395,472 Restricted cash, current — 946 Restricted cash, non-current 2,747 2,694 $ 1,672,051 $ 399,112 Short-Term Investments We determine the appropriate classification of our investments at the time of purchase and reevaluate such determination at each balance sheet date. We classify our investments as available-for-sale securities and present them within current assets as we may liquidate these investments at any time for use in our current operations or for any other purpose. Our investments are recorded at fair value with unrealized gains and losses, if any, reported in accumulated other comprehensive income (loss). Unrealized gains and losses and decline in value that are considered to be other-than-temporary are recognized in other income (expense), net in the consolidated statements of operations. We did not identify any investments with other-than-temporary impairments as of January 31, 2022 and 2021. Realized gains and losses on the sale of short-term investments are determined on a specific identification method and are recorded in other income (expense), net in the consolidated statements of operations. There were no realized gains or losses on the sale of short-term investments during fiscal 2022, 2021 and 2020. Strategic Investments Our strategic investments consist of non-marketable equity investments in privately held companies. We elect to apply the measurement alternative and record these investments at cost, less any impairment, plus or minus observable price changes in orderly transactions for identical or similar investments of the same issuer. Strategic investments are included within other assets on our consolidated balance sheets and adjustments to their carrying amounts are recorded in other income (expense), net in the consolidated statements of operations. There were no material events or circumstances impacting the carrying amount of our strategic investments during fiscal 2022, 2021 and 2020. Deferred Offering Costs Prior to the IPO, all deferred offering costs were capitalized in other assets on the consolidated balance sheets. Deferred offering costs of $7.6 million, primarily consisting of accounting, legal, and other fees related to our IPO, were offset against the IPO proceeds upon the closing of our IPO in July 2021. Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The carrying amounts reported on the consolidated balance sheets for cash equivalents, short-term investments, accounts receivable, accounts payable, accrued liabilities, and accrued payroll and benefits approximate their respective fair values due to their short-term nature. Concentrations of Credit Risk Financial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, short-term investments, and accounts receivable. We maintain our cash, cash equivalents, restricted cash, and short-term investments with high-credit-quality financial institutions mainly in the U.S. and Israel. We have not experienced any credit losses relating to our cash, cash equivalents, restricted cash, and short-term investments. For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheets. We perform periodic credit evaluations of our customers and generally do not require collateral. The only channel partner that represented 10% or more of accounts receivable, net for the periods presented was as follows: As of January 31, 2022 2021 Channel partner A 18 % 23 % There were no end customers that represented 10% or more of accounts receivable as of January 31, 2022 or 2021. Channel partners that represented 10% or more of our total revenue for the periods presented were as follows: Year Ended January 31, 2022 2021 2020 Channel partner A 18 % 19 % 19 % Channel partner B * 13 % 14 % *Less than 10% There were no end customers that represented 10% or more of total revenue for fiscal 2022, 2021 and 2020. Accounts Receivable Accounts receivable are recorded at invoiced amounts and are non-interest bearing. We have a well-established collection history from our channel partners and end customers. We periodically evaluate the collectability of our accounts receivable and provide an allowance for doubtful accounts as necessary, based on the age of the receivable, expected payment ability, and collection experience. As of January 31, 2022 and 2021, the allowance for doubtful accounts was not material. Deferred Contract Acquisition Costs We capitalize sales commissions and associated payroll taxes that are incremental to obtaining a customer contract, which are recorded as deferred contract acquisition costs on the consolidated balance sheets. Sales commissions for the renewal of a contract are not considered commensurate with commissions paid for the initial contracts, given the substantive difference in commission rates in proportion to their respective contract values. Commissions paid on a new contract are amortized on a straight-line basis over an estimated period of benefit of four years, while commissions paid on renewal contracts are amortized over the contractual term of the renewal. We determine the estimated period of benefit based on both quantitative and qualitative factors, including the duration of our relationships with customers and the estimated useful life of our technology. Amortization of deferred contract acquisition costs is included in sales and marketing expenses in the consolidated statements of operations. We periodically review these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit. We did not recognize any impairment of deferred contract acquisition costs during fiscal 2022, 2021 and 2020. Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets as follows: Estimated Useful Life Office furniture and equipment 5 years Computers, software, and electronic equipment 3 years Capitalized internal-use software 4 years Leasehold improvements Shorter of useful life or remaining term of lease Costs for maintenance and repairs are expensed as incurred. Capitalized Internal-Use Software We capitalize certain internal-use software development costs related to our cloud platform. Costs incurred in the preliminary stages of development and post-development are expensed as incurred. Internal and external costs incurred during the development phase, if direct, are capitalized until the software is substantially complete and ready for our intended use. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Maintenance and training costs are expensed as incurred. Capitalized internal-use software is included in property and equipment and is amortized to cost of revenue on a straight-line basis over its expected useful life. Impairment of Long-Lived Assets (Including Goodwill and Intangible Assets) Long-lived assets, including intangible assets with finite lives, are reviewed for impairment when events or changes in circumstances indicate that the carrying amount of asset may not be recoverable. Recoverability of assets is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the asset group. No impairment loss was recorded during fiscal 2022, 2021 and 2020. Goodwill is not amortized but tested for impairment at least annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that impairment may exist. The impairment test consists of a qualitative assessment to determine if the quantitative assessment is required. Goodwill impairment is recognized when the quantitative assessment results in the carrying value of the reporting unit exceeding its fair value, net of related income tax effect, in which case an impairment charge is recorded to goodwill to the extent the carrying value exceeds the fair value, limited to the amount of goodwill. We did not recognize any impairment of goodwill during fiscal 2022. Business Combinations We account for our acquisitions using the acquisition method of accounting. We allocate the fair value of purchase consideration to the tangible and intangible assets acquired, and liabilities assumed, based on their estimated fair values. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain identifiable assets include, but are not limited to, the selection of valuation methodologies, future expected cash flows, discount rates, and useful lives. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition costs, such as legal and consulting fees, are expensed as incurred and are included in general and administrative expenses in the consolidated statements of operations. During the measurement period, which is up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations. See Note 17 for additional information regarding our acquisitions. Leases In accordance with ASC 842, we determine if an arrangement is or contains a lease at inception by evaluating various factors, including if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration and other facts and circumstances. Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized on the consolidated balance sheets at the lease commencement date based on the present value of lease payments over the lease term, which is the non-cancelable period stated in the contract adjusted for any options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease payments consist of the fixed payments under the arrangement, less any lease incentives, such as tenant improvement allowances. Variable costs, such as maintenance and utilities based on actual usage, are not included in the measurement of operating lease ROU assets and operating lease liabilities and are expensed when the event determining the amount of variable consideration to be paid occurs. When the implicit rate of the leases is not determinable, we use an IBR based on the information available at the lease commencement date in determining the present value of lease payments. Lease cost for lease payments is recognized on a straight-line basis over the lease term. We account for lease components and non-lease components as a single lease component. In addition, we do not recognize operating lease ROU assets and operating lease liabilities for leases with lease terms of 12 months or less. In addition, we sublease certain of our unoccupied facilities to third parties. We recognize sublease income on a straight-line basis over the sublease term. We did not have any material finance leases during fiscal 2022, 2021, and 2020. Recently Adopted Accounting Pronouncement s In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . This guidance simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Topic 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill and the allocation of consolidated income taxes to separate financial statements of entities not subject to income tax. We early adopted this guidance on August 1, 2021, which did not have a material impact on our consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This ASU simplifies the measurement of goodwill by eliminating step two of the two-step impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. This ASU requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. We adopted this guidance on February 1, 2021, which did not have a material impact on our consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which provides new authoritative guidance with respect to the measurement of credit losses on financial instruments. This update changes the impairment model for most financial assets and certain other instruments by introducing a current expected credit loss (CECL) model. The CECL model is a more forward-looking approach based on expected losses rather than incurred losses, requiring entities to estimate and record losses expected over the remaining contractual life of an asset. We adopted this guidance on February 1, 2021, which did not have a material impact on our consolidated financial statements. Recent Accounting Pronouncements Not Yet Adopted In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with Accounting Standards Codification (ASC) Topic 606 as if the acquirer had originated the contracts. The guidance is effective for us on February 1, 2023. We are currently evaluating the impact of this guidance on our consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

Revenue and Contract Balances

Revenue and Contract Balances	12 Months Ended
	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue and Contract Balances	REVENUE AND CONTRACT BALANCES Disaggregation of Revenue The following table summarizes revenue by geography based on the shipping address of end customers who have contracted to use our platform for the periods presented (in thousands, except percentages): Year Ended January 31, 2022 2021 2020 Amount % of Revenue Amount % of Revenue Amount % of Revenue United States $ 140,034 68 % $ 65,497 70 % $ 33,972 73 % International 64,765 32 27,559 30 12,502 27 Total $ 204,799 100 % $ 93,056 100 % $ 46,474 100 % No single country other than the United States represented 10% or more of our revenue during fiscal 2022, 2021 and 2020. The following table summarizes revenue from contracts by type of customer for the periods presented (in thousands, except percentages): Year Ended January 31, 2022 2021 2020 Amount % of Revenue Amount % of Revenue Amount % of Revenue Channel partners $ 187,541 92 % $ 88,954 96 % $ 42,881 92 % Direct customers 17,258 8 4,102 4 $ 3,593 8 Total $ 204,799 100 % $ 93,056 100 % $ 46,474 100 % Contract Balances Contract assets consist of unbilled accounts receivable, which arise when a right to consideration for our performance under the customer contract occurs before invoicing the customer. The amount of unbilled accounts receivable included within accounts receivable, net on the consolidated balance sheets was $1.5 million as of both January 31, 2022 and 2021. Contract liabilities consist of deferred revenue, which represents invoices billed in advance of performance under a contract. Deferred revenue is recognized as revenue over the contractual period. The deferred revenue balance was $262.0 million and $141.8 million as of January 31, 2022 and 2021, respectively. We recognized revenue of $95.5 million, $53.8 million and $25.9 million for fiscal 2022, 2021 and 2020, respectively, that was included in the corresponding contract liability balance at the beginning of the period. Remaining Performance Obligations Our contracts with customers typically range from one As of January 31, 2022, our remaining performance obligations were $345.4 million, of which we expect to recognize 90% as revenue over the next 24 months, with the remainder to be recognized thereafter.

Fair Value Measurements

Fair Value Measurements	12 Months Ended
	Jan. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value Measurements	FAIR VALUE MEASUREMENTS We measure fair value based on a three-level hierarchy, maximizing the use of observable inputs, where available, and minimizing the use of unobservable inputs, as follows: Level 1: Assets and liabilities whose values are based on observable inputs such as quoted (unadjusted) prices in active markets for identical assets or liabilities. Level 2: Assets and liabilities whose values are based on inputs from quoted prices for similar assets and liabilities in active markets or inputs that are observable for the asset or liability, either directly or indirectly through market corroboration, for substantially the full term of the asset or liability. Level 3: Assets and liabilities whose values are based on unobservable inputs that are supported by little or no market activity and that are significant to the overall fair value measurement. The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): As of January 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 1,641,642 $ — $ — $ 1,641,642 Short-term investments: Certificates of deposit — 375 — 375 Total assets measured and recorded at fair value $ 1,641,642 $ 375 $ — $ 1,642,017 As of January 31, 2021 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 40,518 $ — $ — $ 40,518 Short-term investments: Certificates of deposit — 364 — 364 Total assets measured and recorded at fair value $ 40,518 $ 364 $ — $ 40,882 There were no transfers between the levels of the fair value hierarchy during fiscal 2022, 2021 and 2020. As of January 31, 2022 and 2021, the aggregate fair value of our cash equivalents and short-term investments approximated amortized cost and, as such, there were no unrealized gains or losses, either individually or in the aggregate. As of January 31, 2022 and 2021, our cash and cash equivalents had contractual maturities of three months or less and short-term investments had contractual maturities within one year of each respective date. The table above does not include our strategic investments in privately held equity securities, which are measured using the alternative measurement method. As of January 31, 2022, our non-marketable equity investments of $6.0 million was included in other assets on the consolidated balance sheets. We did not have any strategic investments as of January 31, 2021.

Property and Equipment, Net

Property and Equipment, Net	12 Months Ended
	Jan. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	PROPERTY AND EQUIPMENT, NET Property and equipment, net consisted of the following (in thousands): As of January 31, 2022 2021 Office furniture and equipment $ 1,318 $ 837 Computers, software, and electronic equipment 4,895 3,489 Capitalized internal-use software 17,917 6,959 Leasehold improvements 7,490 4,568 Construction in progress 3,108 2,925 Total property and equipment 34,728 18,778 Less: Accumulated depreciation and amortization (9,810) (5,405) Total property and equipment, net $ 24,918 $ 13,373 We capitalized internal-use software costs of $10.6 million, $2.8 million and $1.7 million during fiscal 2022, 2021 and 2020, respectively.

Intangible Assets

Intangible Assets	12 Months Ended
	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	INTANGIBLE ASSETS Intangible assets, net as of January 31, 2022 consisted of the following (in thousands): As of January 31, 2022 Developed technology $ 15,500 Customer relationship 1,500 Non-compete agreements 650 Trademarks 150 Patents 1,094 Total finite-lived intangible assets 18,894 Less: accumulated amortization (3,342) Total finite-lived intangible assets, net $ 15,552 Indefinite-lived intangible assets - domain names $ 255 Total intangible assets, net $ 15,807 Intangible assets, net as of January 31, 2021 were not material. Amortization expense of intangible assets was $3.3 million for fiscal 2022. Amortization expense of intangible assets was not material for fiscal 2021 and 2020. As of January 31, 2022, estimated future amortization expense is as follows (in thousands): Fiscal Year Ending January 31, 2023 3,381 2024 2,578 2025 2,353 2026 2,341 2027 2,341 Thereafter 2,558 Total $ 15,552

Long-Term Debt

Long-Term Debt	12 Months Ended
	Jan. 31, 2022
Debt Disclosure [Abstract]
Long-Term Debt	LONG-TERM DEBT In May 2018, we entered into a loan and security agreement with a certain lender, which was restated in May 2020, or the Amended Loan and Security Agreement. The Amended Loan and Security Agreement provided a revolving line of credit of up to $45.0 million, maturing in May 2023. In June 2021, we repaid all outstanding indebtedness owed pursuant to the Amended Loan and Security Agreement, terminated the agreement, and closed our revolving line of credit. Pursuant to our termination of the Amended Loan and Security Agreement, the related security interests have been removed and the covenants shall be of no further force and effect. In connection with the initial term loan, we issued warrants to purchase shares of common stock with an exercise price of $0.62 per share. The remaining warrants to purchase 954,884 shares of common stock were outstanding and exercisable as of January 31, 2021. Upon the closing of the IPO, we issued 940,953 shares of Class B common stock in connection with the cashless exercise of all outstanding warrants to purchase common stock.

Leases

Leases	12 Months Ended
	Jan. 31, 2022
Leases [Abstract]
Leases	LEASES We have entered into non-cancelable operating lease agreements with various expiration dates through fiscal 2029. Our operating lease arrangements do not contain any restrictive covenants or residual value guarantees. Supplemental cash flow information related to our operating leases for fiscal 2022 and 2021 as well as the weighted-average remaining lease term and weighted-average discount rate as of January 31, 2022 and 2021 were as follows: Year Ended January 31, 2022 2021 Supplemental Cash Flow Information Cash paid for amount included in the measurement of operating lease liabilities $ 4,596 $ 3,999 Operating lease ROU assets obtained in exchange for operating lease liabilities $ 8,558 $ 6,579 As of January 31, 2022 2021 Lease Term and Discount Rate Weighted-average remaining lease term (years) 6.56 7.42 Weighted-average discount rate 4.3 % 4.3 % The components of lease costs consisted of the following (in thousands): Year Ended January 31, 2022 2021 Operating lease costs $ 4,027 $ 3,844 Short-term lease costs 2,248 509 Variable lease costs 1,124 702 Total lease costs $ 7,399 $ 5,055 Sublease income was $0.6 million, $0.9 million and $1.0 million for fiscal 2022, 2021 and 2020, respectively, and was recorded as a reduction of lease costs. As of January 31, 2022, we had total undiscounted future payments of $3.6 million under an operating lease that had not yet commenced, which were not included on the consolidated balance sheets. This operating lease commenced in February 2022 and has a lease term of 6 years. The maturities of our non-cancelable operating lease liabilities as of January 31, 2022 were as follows (in thousands): Fiscal Year Ending January 31, Amount 2023 4,926 2024 5,188 2025 5,109 2026 5,168 2027 5,229 Thereafter 7,845 Total operating lease payments $ 33,465 Less: Imputed interest (4,385) Present value of operating lease liabilities $ 29,080

Preferred Stock

Preferred Stock	12 Months Ended
	Jan. 31, 2022
Equity [Abstract]
Preferred Stock	PREFERRED STOCK Redeemable Convertible Preferred Stock Upon the closing of the IPO, all 167,058,113 shares of our then-outstanding redeemable convertible preferred stock automatically converted to an aggregate of 169,787,200 shares of class B common stock. All of our redeemable convertible preferred stock converted on a one-to-one basis, other than 31,405,183 shares of our then-outstanding Series E redeemable convertible preferred stock, which converted into 34,134,270 shares of Class B common stock. Our redeemable convertible preferred stock as of January 31, 2021 consisted of the following (in thousands, except share and per share data): As of January 31, 2021 Shares Authorized Shares Issued and Outstanding Liquidation Amount Carrying Value Original Issuance Price per Share Series Seed 10,962,327 10,962,327 $ 2,577 $ 2,553 $ 0.2351 Series A 12,855,123 12,855,123 10,000 9,948 0.7779 Series B 20,288,700 20,288,700 24,338 24,241 1.1996 Series C 40,338,867 40,338,867 70,433 69,845 1.7460 Series D 29,078,931 29,078,931 95,476 95,239 3.2833 Series E 31,405,183 31,405,183 152,683 152,539 4.8617 Series F 24,056,282 22,128,982 266,907 266,774 12.0614 Total 168,985,413 167,058,113 $ 622,414 $ 621,139 During fiscal 2021, we issued 31,405,183 shares of Series E Preferred Stock at a price of $4.8617 per share for aggregate proceeds of $152.5 million, net of issuance costs of $0.1 million and 22,128,982 shares of Series F Preferred Stock at a price of $12.0614 per share for aggregate proceeds of $266.8 million, net of issuance costs of $0.1 million. Preferred Stock In connection with the IPO, we amended and restated our certificate of incorporation, which became effective immediately prior to the closing of the IPO, which authorized 50,000,000 shares of undesignated preferred stock, with a par value of $0.0001. As of January 31, 2022, there were 50,000,000 shares of preferred stock authorized and no shares of preferred stock outstanding. We have two classes of common stock: Class A common stock and Class B common stock. In connection with the IPO, we amended and restated our certificate of incorporation and authorized 1,500,000,000 shares of Class A common stock and 300,000,000 shares of Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to twenty votes. Class A and Class B common stock each have a par value of $0.0001 per share, and are referred to collectively as our common stock throughout the notes to the consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. Shares of Class B common stock automatically convert to Class A common stock at the earlier of: (i) the date specified by a vote of the holders of 66 2/3% of the then outstanding shares of Class B common stock, (ii) seven years from the date of our Final Prospectus, or June 29, 2028, (iii) the first date following the completion of our IPO on which the number of shares of outstanding Class B common stock (such calculations shall include shares of Class B common stock subject to outstanding stock options) held by Tomer Weingarten, including certain permitted entities that Mr. Weingarten controls, is less than 25% of the number of shares of outstanding Class B common stock (such calculation shall include shares of Class B common stock subject to outstanding stock options) that Mr. Weingarten originally held as of the date of our Final Prospectus, (iv) the date fixed by our board of directors, following the first date following the completion of our IPO when Mr. Weingarten is no longer providing services to us as an officer, employee, consultant or member of our board of directors, (v) the date fixed by our board of directors following the date on which, if applicable, Mr. Weingarten is terminated for cause, as defined in our restated certificate of incorporation, and (vi) the date that is 12 months after the death or disability, as defined in our restated certificate of incorporation, of Mr. Weingarten. Our common stock reserved for future issuance on an as-converted basis as of January 31, 2022 and 2021 were as follows: As of January 31, 2022 2021 Conversion of redeemable convertible preferred stock — 168,951,059 Exercise of common stock warrants — 954,884 Stock options outstanding 42,422,473 37,231,191 RSUs outstanding 1,770,304 — ESPP reserved for future issuance 6,674,603 — 2021 Plan available for future grants 38,055,572 5,642,142 Total shares of common stock reserved 88,922,952 212,779,276

Common Stock

Common Stock	12 Months Ended
	Jan. 31, 2022
Equity [Abstract]
Common Stock	PREFERRED STOCK Redeemable Convertible Preferred Stock Upon the closing of the IPO, all 167,058,113 shares of our then-outstanding redeemable convertible preferred stock automatically converted to an aggregate of 169,787,200 shares of class B common stock. All of our redeemable convertible preferred stock converted on a one-to-one basis, other than 31,405,183 shares of our then-outstanding Series E redeemable convertible preferred stock, which converted into 34,134,270 shares of Class B common stock. Our redeemable convertible preferred stock as of January 31, 2021 consisted of the following (in thousands, except share and per share data): As of January 31, 2021 Shares Authorized Shares Issued and Outstanding Liquidation Amount Carrying Value Original Issuance Price per Share Series Seed 10,962,327 10,962,327 $ 2,577 $ 2,553 $ 0.2351 Series A 12,855,123 12,855,123 10,000 9,948 0.7779 Series B 20,288,700 20,288,700 24,338 24,241 1.1996 Series C 40,338,867 40,338,867 70,433 69,845 1.7460 Series D 29,078,931 29,078,931 95,476 95,239 3.2833 Series E 31,405,183 31,405,183 152,683 152,539 4.8617 Series F 24,056,282 22,128,982 266,907 266,774 12.0614 Total 168,985,413 167,058,113 $ 622,414 $ 621,139 During fiscal 2021, we issued 31,405,183 shares of Series E Preferred Stock at a price of $4.8617 per share for aggregate proceeds of $152.5 million, net of issuance costs of $0.1 million and 22,128,982 shares of Series F Preferred Stock at a price of $12.0614 per share for aggregate proceeds of $266.8 million, net of issuance costs of $0.1 million. Preferred Stock In connection with the IPO, we amended and restated our certificate of incorporation, which became effective immediately prior to the closing of the IPO, which authorized 50,000,000 shares of undesignated preferred stock, with a par value of $0.0001. As of January 31, 2022, there were 50,000,000 shares of preferred stock authorized and no shares of preferred stock outstanding. We have two classes of common stock: Class A common stock and Class B common stock. In connection with the IPO, we amended and restated our certificate of incorporation and authorized 1,500,000,000 shares of Class A common stock and 300,000,000 shares of Class B common stock. The shares of Class A common stock and Class B common stock are identical, except with respect to voting rights. Each share of Class A common stock is entitled to one vote. Each share of Class B common stock is entitled to twenty votes. Class A and Class B common stock each have a par value of $0.0001 per share, and are referred to collectively as our common stock throughout the notes to the consolidated financial statements, unless otherwise noted. Holders of common stock are entitled to receive any dividends as may be declared from time to time by the board of directors. Shares of Class B common stock may be converted to Class A common stock at any time at the option of the stockholder. Shares of Class B common stock automatically convert to Class A common stock at the earlier of: (i) the date specified by a vote of the holders of 66 2/3% of the then outstanding shares of Class B common stock, (ii) seven years from the date of our Final Prospectus, or June 29, 2028, (iii) the first date following the completion of our IPO on which the number of shares of outstanding Class B common stock (such calculations shall include shares of Class B common stock subject to outstanding stock options) held by Tomer Weingarten, including certain permitted entities that Mr. Weingarten controls, is less than 25% of the number of shares of outstanding Class B common stock (such calculation shall include shares of Class B common stock subject to outstanding stock options) that Mr. Weingarten originally held as of the date of our Final Prospectus, (iv) the date fixed by our board of directors, following the first date following the completion of our IPO when Mr. Weingarten is no longer providing services to us as an officer, employee, consultant or member of our board of directors, (v) the date fixed by our board of directors following the date on which, if applicable, Mr. Weingarten is terminated for cause, as defined in our restated certificate of incorporation, and (vi) the date that is 12 months after the death or disability, as defined in our restated certificate of incorporation, of Mr. Weingarten. Our common stock reserved for future issuance on an as-converted basis as of January 31, 2022 and 2021 were as follows: As of January 31, 2022 2021 Conversion of redeemable convertible preferred stock — 168,951,059 Exercise of common stock warrants — 954,884 Stock options outstanding 42,422,473 37,231,191 RSUs outstanding 1,770,304 — ESPP reserved for future issuance 6,674,603 — 2021 Plan available for future grants 38,055,572 5,642,142 Total shares of common stock reserved 88,922,952 212,779,276

Stock-Based Compensation

Stock-Based Compensation	12 Months Ended
	Jan. 31, 2022
Share-based Payment Arrangement [Abstract]
Stock-Based Compensation	STOCK-BASED COMPENSATION 2021 Equity Incentive Plan In May 2021, our board of directors and in June 2021, our stockholders approved our 2021 Equity Incentive Plan (2021 Plan) as a successor to our 2013 Equity Incentive Plan (2013 Plan) and 2011 Stock Incentive Plan (2011 Plan) with the purpose of granting stock-based awards to employees, directors, officers and consultants, including stock options, restricted stock awards and restricted stock units (RSUs). A total of 35,281,596 shares of Class A common stock were initially available for issuance under the 2021 Plan. Our compensation committee administers the 2021 Plan. The number of shares of our Class A common stock available for issuance under the 2021 Plan is subject to an annual increase on the first day of each fiscal year beginning on February 1, 2022, equal to the lesser of: (i) five percent (5%) of the aggregate number of outstanding shares of all classes of our common stock as of the last day of the immediately preceding fiscal year or (ii) such other amount as our board of directors may determine. The 2013 Plan and 2011 Plan (together, the Prior Plans) were terminated in July 2021, in connection with the adoption of our 2021 Plan, and stock-based awards are no longer granted under the Prior Plans. However, the Prior Plans will continue to govern the terms and conditions of the outstanding awards previously granted thereunder. Any shares underlying stock options that are expired, canceled, forfeited or repurchased under the Prior Plans will be automatically transferred to the 2021 Plan and be available for issuance as Class A common stock. Restricted Stock Units A summary of our RSUs under the 2021 Plan is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2021 — $ — Granted 1,491,253 $ 57.17 Released (11,902) $ 62.60 Forfeited (41,998) $ 54.29 Outstanding as of January 31, 2022 1,437,353 $ 57.21 As of January 31, 2022, we had unrecognized stock-based compensation expense related to unvested RSUs of $77.0 million that is expected to be recognized on a straight-line basis over a weighted-average period of 3.7 years. 2013 Equity Incentive Plan Our 2013 Plan was adopted by our board of directors in June 2013 and approved by our stockholders in July 2013. The 2013 Plan provides for the grant of stock-based awards to employees, officers, directors, and other service providers. Options granted under the 2013 Plan expire ten years from the date of grant. The options generally vest 25% on the first anniversary of the grant date and monthly over the course of the following three years. A summary of our stock option plan activity under the 2013 Plan is as follows: Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2021 37,231,191 $ 1.68 8.34 $ 442,515 Granted 14,048,623 $ 9.66 Exercised (8,406,950) $ 1.52 Forfeited (1,131,723) $ 3.34 Outstanding as of January 31, 2022 41,741,141 $ 4.34 7.95 $ 1,686,738 Expected to vest as of January 31, 2022 41,741,141 $ 4.34 7.95 $ 1,686,738 Vested and exercisable as of January 31, 2022 17,467,223 $ 2.47 7.16 $ 738,584 The weighted-average grant-date fair value of options granted during fiscal 2022, 2021 and 2020 were $13.14, $1.63 and $0.43 per share, respectively. The aggregate grant-date fair value of options vested during fiscal 2022, 2021 and 2020 was $32.0 million, $5.1 million and $1.5 million, respectively. The aggregate intrinsic value is the difference between the exercise price and the estimated fair value of the underlying common stock. The aggregate intrinsic value of options exercised during fiscal 2022, 2021 and 2020 was $333.7 million, $27.0 million and $1.7 million, respectively. As of January 31, 2022, we had unrecognized stock-based compensation expense related to unvested options of $148.6 million that is expected to be recognized on a straight-line basis over a weighted-average period of 2.8 years. Restricted Stock Units A summary of our RSUs under the 2013 Plan is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2021 — $ — Granted 346,483 $ 32.39 Released (3,316) $ 32.69 Forfeited (10,216) $ 32.48 Outstanding as of January 31, 2022 332,951 $ 32.38 As of January 31, 2022, we had unrecognized stock-based compensation expense related to unvested RSUs of $6.8 million that is expected to be recognized on a straight-line basis over a weighted-average period of 1.6 years. Performance Milestone Options In February 2021, we granted 1,243,636 performance milestone options to purchase shares of common stock under the 2013 Plan. The performance milestone options are subject to service-based vesting conditions and achievements of certain milestones. We recognize compensation cost on a graded basis over the total requisite service period for each separately vesting portion of the performance tranches related to these performance milestone options. The grant-date fair value of the performance milestone options was $10.25, $10.37, and $10.49 per share for each of the performance tranches using the Black-Scholes option-pricing model. We assess the probability that the performance condition will be met for each of the performance tranches at the end of each reporting period, and recognize cumulative expense only for the performance tranches that are assessed to be probable of vesting. During fiscal 2022, we recorded $12.8 million of stock-based compensation expense. As of January 31, 2022, we had fully recognized stock-based compensation expense related to performance milestone options. Milestone Options In March 2021, we granted 1,404,605 options to purchase shares of common stock subject to service-based, performance-based, and market-based vesting conditions to our Chief Executive Officer and Chief Financial Officer under the 2013 Plan. These stock options will vest 100% upon the occurrence of our IPO (the performance-based vesting condition) and the achievement of certain milestone events and our share price targets (the market-based vesting conditions), subject to the executive’s continued service to us from the grant date through the milestone events. For these options, we used a Monte Carlo simulation to determine the fair value at the grant date and the implied service period. During fiscal 2022, we recorded $3.1 million of stock-based compensation expense. As of January 31, 2022, we had unrecognized stock-based compensation expense related to unvested milestone options of $16.3 million, that is expected to be recognized over the remaining implied service period of 4.6 years. Restricted Common Stock In connection with the Scalyr acquisition, we granted 1,315,099 shares of restricted common stock with a fair value of $14.59 per share at the time of grant, that vest over a period of two years. During fiscal 2022, we recorded $10.9 million of stock-based compensation expense. As of January 31, 2022, we had unrecognized stock-based compensation expense related to this unvested restricted common stock of $8.7 million that is expected to be recognized over the remaining vesting period of 1.0 years. 2011 Stock Incentive Plan As part of the Scalyr acquisition, we assumed 2,138,347 options to purchase shares of common stock under the 2011 Plan, at a weighted-average exercise price of $1.74 per share and weighted-average fair value of $13.10 per share, of which 681,332 options remained outstanding with a weighted-average exercise price of $1.72 per share as of January 31, 2022. As of January 31, 2022, 148,499 options were vested and exercisable with a weighted-average exercise price of $1.72 per share. The aggregate grant-date fair value of options vested during fiscal 2022 was $10.8 million. The total unrecognized stock-based compensation expense related to these options was $4.1 million, that is expected to be recognized on a straight-line basis over a weighted-average period of 1.2 years. During fiscal 2022, 1,386,381 options were exercised with an aggregate intrinsic value of $33.4 million. Secondary Stock Sales In May 2021, we facilitated a secondary sale of our common stock. Under the terms of the sale, certain preferred stock investors purchased 85,403 shares of common stock from an employee at $23.00 per share for an aggregate purchase price of $2.0 million. We did not recognize any stock-based compensation expense during fiscal 2022 in connection with this sale. In June 2021, we facilitated certain secondary sales of our common stock. Under the terms of the sales, certain preferred stock investors purchased 305,724 shares of common stock from certain employees at prices ranging from $21.00 to $52.00 per share for an aggregate purchase price of $8.7 million. The stock-based compensation expense recognized in connection with these sales were not material. Common Stock Subject to Repurchase Common stock purchased by employees pursuant to an early exercise of stock options are not deemed, for accounting purposes, to be outstanding until those shares vest according to their respective vesting schedules and accordingly, the consideration received for early exercises are initially recorded as a liability and reclassified to common stock and additional paid-in capital as the underlying awards vest. These unvested shares may be repurchased by us in case of employment termination at the price paid by the purchaser for such shares. As of January 31, 2022 and 2021, the balance of common stock subject to repurchase was not material. Stock-Based Compensation Expense We estimate the fair value of stock options granted using the Black-Scholes option pricing model based on the following assumptions: Expected term – We determine expected term based on the average period the options are expected to remain outstanding using the simplified method, calculated as the midpoint of the options’ vesting term and contractual expiration period, until sufficient historical information to develop reasonable expectations about future exercise patterns and post-vesting employment termination behavior becomes available. Expected volatility – Since there is little trading history of our common stock, expected volatility is estimated based on the historical volatilities of a group of comparable publicly traded companies. Risk-free interest rate – The risk-free interest rate is based on U.S. Treasury yields for a period that corresponds with the expected term of the award. Dividend yield – As we do not currently issue dividends and do not expect to issue dividends on our common stock in the foreseeable future, the expected dividend yield is zero. Fair value of underlying common stock – Prior to the completion of our IPO, the fair value of our common stock was determined by the board of directors by considering a number of objective and subjective factors including input from management and contemporaneous third-party valuations. After the completion of our IPO, the fair value of our Class A common stock is determined by the closing price of our Class A common stock, which is traded on the New York Stock Exchange. Year Ended January 31, 2022 2021 Expected term (in years) 6.0 6.0 Expected volatility 62.3% - 66.0% 47.3% - 48.7% Risk-free interest rate 0.8% - 1.1% 0.4% - 0.6% Dividend yield — % — % The components of stock-based compensation expense recognized in the consolidated statements of operations consisted of the following (in thousands): Year Ended January 31, 2022 2021 Cost of revenue $ 3,618 $ 308 Research and development 35,358 6,590 Sales and marketing 15,460 3,835 General and administrative 33,453 5,179 Total $ 87,889 $ 15,912 Employee Stock Purchase Plan In May 2021, our board of directors, and in June 2021, our stockholders approved our ESPP, which became effective on the date of effectiveness of our Final Prospectus, or June 29, 2021. The ESPP initially reserved and authorized the issuance of up to a total of 7,056,319 shares of common stock to eligible employees. The number of shares reserved for issuance and sale under the ESPP will automatically increase on the first day of each fiscal year, starting on February 1, 2022 for the first ten The following table summarizes assumptions used in estimating the fair value of employee stock purchase rights for the initial and second offering period under the 2021 ESPP using the Black-Scholes option pricing model: Year Ended Expected term (in years) 0.5 - 2 Expected volatility 52.3% - 70.5% Risk-free interest rate 0.1% - 0.3% Dividend yield — % We recognized stock-based compensation expense related to ESPP of $5.5 million during fiscal 2022. As of January 31, 2022, $1.6 million amount has been withheld on behalf of employees for a future purchase under the ESPP due to the timing of payroll deductions. During fiscal 2022, 381,716 shares were issued under the ESPP for $11.4 million.

Income Taxes

Income Taxes	12 Months Ended
	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Income Taxes	INCOME TAXES Our loss before provision for income taxes for fiscal 2022, 2021 and 2020 consisted of the following (in thousands) : Year Ended January 31, 2022 2021 2020 Domestic $ (274,270) $ (18,159) $ (1,700) Foreign 4,173 (98,954) (74,630) Loss before provision for income taxes $ (270,097) $ (117,113) $ (76,330) The components of provision for income taxes for fiscal 2022, 2021, and 2020 consisted of the following (in thousands): Year Ended January 31, 2022 2021 2020 Current: State 82 62 52 Foreign 1,011 398 185 Total current 1,093 460 237 Deferred: Foreign (89) — — Total deferred (89) — — Total provision for income taxes $ 1,004 $ 460 $ 237 A reconciliation of the expected provision for (benefit from) income taxes at the statutory federal income tax rate to our recorded provision for income taxes consisted of the following (in thousands): Year Ended January 31, 2022 2021 2020 Benefit from income taxes at U.S. federal statutory rate $ (56,720) $ (24,594) $ (16,029) State taxes, net of federal benefit 82 49 41 Foreign tax rate differential (1,297) (1,836) (6,852) Stock-based compensation (23,442) 1,195 771 Non-deductible expenses 322 84 109 Change in valuation allowance 81,739 25,564 22,857 Other 320 (2) (660) Total provision for income taxes $ 1,004 $ 460 $ 237 Significant components of our net deferred tax assets and liabilities as of January 31, 2022 and 2021 consisted of the following (in thousands): As of January 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 174,646 $ 70,735 Research and development expenses 36,989 11,479 Accruals and reserves 18,708 12,986 Operating lease liabilities 11,158 5,416 Stock-based compensation 7,936 140 Other 2,012 532 Gross deferred tax assets 251,449 101,288 Valuation allowance (218,981) (86,032) Total deferred tax assets 32,468 15,256 Deferred tax liabilities: Acquired intangibles, property and equipment (6,235) (1,217) Deferred contract acquisition costs (16,722) (9,697) Operating lease right-of-use assets (9,422) (4,342) Total deferred tax liabilities (32,379) (15,256) Net deferred tax assets $ 89 $ — Based upon available objective evidence, we believe it is more likely than not that the net U.S. and Israel deferred tax assets will not be fully realizable. Accordingly, we have established a valuation allowance for the U.S. and Israel gross deferred tax assets. As of January 31, 2022 and 2021, we had a valuation allowance of $219.0 million and $86.0 million, respectively, against our deferred tax assets. During fiscal 2022 and 2021, total valuation allowance increased by $132.9 million and $28.0 million, respectively, primarily due to additional net operating losses. As of January 31, 2022, we had federal net operating loss carryforwards of $436.8 million, which will begin to expire in 2031, and state net operating loss carryforwards of $268.9 million, which will begin to expire in 2023. We also had foreign net operating loss carryforwards of $281.9 million, which do not expire. In addition, we had federal research and development credit carryforwards of $1.1 million, which will begin to expire in 2037, and state research and development credit carryforwards of $1.1 million, which do not expire. Federal and state tax laws impose substantial restrictions on the utilization of the net operating loss carryforwards and tax credit carryforwards in the event of an ownership change as defined in Section 382 of the Internal Revenue Code of 1986, as amended. Accordingly, our ability to utilize these carryforwards may be limited as a result of such ownership change. Such a limitation could result in the expiration of carryforwards before they are utilized. The carryforwards are currently subject to a valuation allowance. Foreign withholding taxes have not been provided for the cumulative undistributed earnings of certain foreign subsidiaries of us as of January 31, 2022 and 2021 due to our intention to permanently reinvest such earnings. Determination of the amount of unrecognized deferred tax liability related to these earnings is not practicable. As of January 31, 2022 and 2021, we do not have any material uncertain tax positions. As of and for fiscal 2022 and 2021, no interest and penalties have been accrued with respect to unrecognized tax benefits. We file income tax returns in the U.S. federal jurisdiction and various state and foreign jurisdictions. Our tax years generally remain open and subject to examination by federal, state, or foreign tax authorities. We are currently under examination by the Israel Tax Authorities for the 2016 through 2020 tax years. We are not currently under audit in any other tax jurisdictions.

Net Loss Per Share Attributable

Net Loss Per Share Attributable To Common Stockholders	12 Months Ended
	Jan. 31, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS Basic and diluted net loss per share attributable to common stockholders is computed in conformity with the two-class method required for participating securities. Basic net loss per share is computed by dividing net loss attributable to common stockholders by the weighted-average number of shares of common stock outstanding during the period. Diluted net loss per share is computed by giving effect to all potentially dilutive common stock equivalents to the extent they are dilutive. For purposes of this calculation, redeemable convertible preferred stock, stock options, restricted common stocks, RSUs, ESPP, early exercised stock options, and common stock warrants are considered to be common stock equivalents but have been excluded from the calculation of diluted net loss per share attributable to common stockholders as their effect is anti-dilutive for all periods presented. The rights, including the liquidation and dividend rights, of the holders of Class A and Class B common stock are identical, except with respect to voting, conversion, and transfer rights. As the liquidation and dividend rights are identical, the undistributed earnings are allocated on a proportionate basis to each class of common stock and the resulting basic and diluted net loss per share attributable to common stockholders are, therefore, the same for both Class A and Class B common stock on both individual and combined basis. Basic and diluted net loss per share attributable to common stockholders was as follows (in thousands, except share and per share data): Year Ended January 31, 2022 2021 2020 Numerator: Net loss attributable to Class A and Class B common stockholders $ (271,101) $ (117,573) $ (76,567) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 174,051,203 35,482,444 32,712,350 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (1.56) $ (3.31) $ (2.34) The following potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive: As of January 31, 2022 2021 2020 Redeemable convertible preferred stock — 168,951,059 113,523,948 Stock options 42,422,473 37,231,191 26,892,219 Common stock warrants — 954,884 1,276,686 Shares subject to repurchase 20,091 37,500 42,500 RSUs 1,770,304 — — ESPP 52,381 — — Restricted common stock 1,142,496 — — Contingently issuable shares 1,317,079 — — Total 46,724,824 207,174,634 141,735,353

Geographic Information

Geographic Information	12 Months Ended
	Jan. 31, 2022
Segment Reporting [Abstract]
Geographic Information	GEOGRAPHIC INFORMATION Long-lived assets, consisting of property and equipment, net, and operating lease right-of-use assets, by geography were as follows (in thousands): As of January 31, 2022 2021 United States $ 21,176 $ 10,386 Israel 26,646 20,987 Rest of world 980 26 Total $ 48,802 $ 31,399

Commitment and Contingencies

Commitment and Contingencies	12 Months Ended
	Jan. 31, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	COMMITMENTS AND CONTINGENCIES Legal Contingencies From time to time, we may be a party to various legal proceedings and subject to claims in the ordinary course of business. BlackBerry Litigation Starting in October 2019, BlackBerry Corp. and its subsidiary Cylance, Inc. (BlackBerry) filed a total of nine proceedings (seven lawsuits and two arbitrations) against us and certain former BlackBerry employees who joined our company. In these proceedings, BlackBerry alleges that it has viable legal claims as a result of its former employees joining us. Many of these proceedings have now been dismissed. The status of each of the currently pending proceedings is discussed below. We have defended against these claims and expect to continue to defend against these claims. BlackBerry Corp., et al. v. Coulter, et al. On October 17, 2019, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Coulter, et al., No. 953-10-19 (Vt. Super. Ct.) (Vermont Action) against Chris Coulter, an employee on our Vigilance services team. On October 23, 2019, BlackBerry filed an amended complaint that added us as a defendant. The amended complaint asserts claims against us for conspiracy, tortious interference with contract, aiding and abetting breach of fiduciary duties, and misappropriation of trade secrets. The court entered a preliminary injunction order enjoining Mr. Coulter from working for us through February 2021. As a result of the court’s order, Mr. Coulter chose to seek other employment and is no longer employed by us. On January 15, 2021, the court entered an order narrowing the scope of the case and limiting the claims against us in order to avoid conflict with a similar action that was previously filed in California and was dismissed. The Vermont Action is currently pending. On October 25, 2019, BlackBerry commenced an action captioned BlackBerry Corp., et al v. Coulter, et al., No. 2019-0854-JTL (Del. Ch.) against Mr. Coulter and us in Delaware Chancery Court. The court stayed this case pending resolution of the Vermont Action, and on February 7, 2020, BlackBerry voluntarily dismissed without prejudice all claims against Mr. Coulter and us. On December 3, 2019, BlackBerry initiated a largely duplicative action in arbitration solely against Mr. Coulter administered by JAMS, an alternative dispute resolution provider. That arbitration action, however, was dismissed on or about March 30, 2021, with JAMS informing us that they had closed their files on this matter on April 30, 2021. BlackBerry Corp., et al. v. Page, et al. On November 18, 2019, BlackBerry commenced an action captioned BlackBerry Corp., et al. v. Page, et al., No. 2019-CP-07-2552 (S.C. Cir. Ct.) against Barnaby Page, a go-to-market employee, and us, in a South Carolina state court. The complaint asserts claims against us for aiding and abetting breach of fiduciary duties, tortious interference with contract, and misappropriation of trade secrets. Following initial discovery, on August 27, 2020, we and Mr. Page filed a joint motion for judgment on the pleadings. Following initial discovery, the parties agreed to stipulate to a dismissal of this lawsuit without prejudice, and a dismissal order was entered by the court on January 31, 2022. Blackberry Corp. et al. v. Sentinel Labs, Inc., et al. On January 16, 2020, BlackBerry commenced the action captioned, BlackBerry Corp., et al. v. Sentinel Labs, Inc., et al., No. 20CV361950 (Cal. Super. Ct. Santa Clara Cnty.) (Current California Action), against us and unnamed “Doe” defendants, asserting claims against us for trade secret misappropriation and unfair business practices. We filed counterclaims that, in part, seek to invalidate any agreements allegedly supporting BlackBerry’s claims against its former employees. On December 14, 2020, we filed a motion requesting that BlackBerry sufficiently identify any trade secrets it alleges we misappropriated in accordance with California law. On February 12, 2021, the court granted that motion in part, including striking BlackBerry’s expert testimony, and limiting the scope of discovery to customer lists and sales-related information. On March 15, 2021, BlackBerry re-filed a statement identifying its trade secrets to pursue broader claims and discovery. In response, on April 5, 2021, we again filed a motion requesting that BlackBerry sufficiently identify any trade secrets under California law. On June 2, 2021, the court granted the motion in our favor, absent a few discrete areas permitted by the court. On July 2, 2021, Blackberry filed its third amended trade secret identification. In response, on July 16, 2021, we submitted a motion challenging these claims. In its third trade secret statement, in response to our motion again challenging the sufficiency of its trade secret disclosures, Blackberry voluntarily dropped various claims. The parties are currently in the early stages of discovery over the revised trade secret disclosures approved by the court on August 31, 2021. We continue to litigate this action, including actively pursuing our counterclaims against them. BlackBerry Corp., et al. v. Quinn, et al. On February 17, 2020, BlackBerry commenced the action captioned BlackBerry Corp., et al. v. Quinn, et al., No. D-1-GN-20-00096 (Tex. Civ. Ct. – Travis Cnty.) against Sean Quinn, a go-to-market employee, and us, in Texas state court. On August 8, 2020, we and Mr. Quinn moved to stay or dismiss the case in light of the overlapping issues between this case and the Current California Action. On September 21, 2020, the court stayed this case pending resolution of the Current California Action. This lawsuit remains stayed and is pending in abeyance before the Texas court. We have not recorded any accruals for loss contingencies associated with these legal proceedings, determined that an unfavorable outcome is probable, nor have we determined that the amount or range of any possible loss is reasonably estimable. We believe that there are no other pending or threatened legal proceedings that are likely to have a material adverse effect on our consolidated financial statements. Warranties and Indemnification Our services are generally warranted to deliver and operate in a manner consistent with general industry standards that are reasonably applicable and materially conform with our documentation under normal use and circumstances. Our contracts generally include certain provisions for indemnifying customers against liabilities if our products or services infringe a third party’s intellectual property rights. We also offer a limited warranty to certain customers, subject to certain conditions, to cover certain costs incurred by the customer in case of a cybersecurity breach on us. We have entered into an insurance policy to cover our potential liability arising from this limited warranty arrangement. We have not incurred any material costs related to such obligations and have not accrued any liabilities related to such obligations in the consolidated financial statements as of January 31, 2022 and 2021. In addition, we also indemnify certain of our directors and executive officers against certain liabilities that may arise while they are serving in good faith in their company capacities. We maintain director and officer insurance coverage that would generally enable us to recover a portion of any future amounts paid.

Employee Benefit Plan

Employee Benefit Plan	12 Months Ended
	Jan. 31, 2022
Retirement Benefits [Abstract]
Employee Benefit Plan	EMPLOYEE BENEFIT PLANOur U.S. employees participate in a 401(k) defined contribution plan sponsored by us. Contributions to the plan are discretionary. There were no matching contributions by us for fiscal 2022, 2021, and 2020. Israeli Severance Pay Israeli labor law generally requires payment of severance pay upon dismissal of an employee or upon termination of employment in certain other circumstances. Pursuant to Section 14 of the Severance Compensation Act, 1963 (Section 14), all of our employees in Israel are entitled to monthly deposits made in their name with insurance companies, at a rate of 8.33% of their monthly salary. These payments release us from any future severance payment obligation with respect to these employees; as such, any liability for severance pay due to these employees and the deposits under Section 14 are not recorded as an asset on our consolidated balance sheets. For fiscal 2022, 2021, and 2020, we recorded $3.7 million, $2.7 million, and $1.7 million, respectively, in severance expenses related to these employees.

Acquisitions

Acquisitions	12 Months Ended
	Jan. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	ACQUISITIONS On February 6, 2021, we executed a merger agreement to acquire 100% of the issued and outstanding equity securities of Scalyr, a leading cloud-native, cloud-scale data analytics platform. This acquisition allows us to advance our data ingestion, search, and retention capabilities. This acquisition closed on February 9, 2021. The aggregate consideration transferred was $125.3 million, of which $5.0 million was paid in cash, $106.2 million was comprised of 7,277,214 shares of common stock, and $14.1 million was comprised of assumed options to purchase 2,138,347 shares of common stock. As part of the merger agreement, we entered into non-compete agreements with the founder and the co-founder of Scalyr with a term of three years and a fair value of $0.7 million. The fair value of the non-compete agreements was excluded from the purchase consideration and the net assets acquired, resulting in purchase consideration of $124.6 million. The assets acquired and liabilities assumed in connection with the acquisition were recorded at their fair value on the date of acquisition as follows (in thousands): Amount Cash and cash equivalents $ 699 Accounts receivable 3,665 Restricted cash 444 Prepaid expense 277 Intangible assets 17,150 Goodwill 108,193 Accounts payable (412) Deferred revenue (5,041) Other liabilities (347) Total purchase consideration $ 124,628 The excess of the purchase price over the fair value of net tangible and intangible assets acquired has been assigned to goodwill. Goodwill represents the future benefits as a result of the acquisition that will enhance our product available to both new and existing customers and increase our competitive position. Goodwill is not deductible for tax purposes. The following table sets forth the amounts allocated to the intangible assets identified and their estimated useful lives as of the date of acquisition: Fair Value Useful Life (in thousands) (in years) Developed technology $ 15,500 7 Customer relationships 1,500 2 Trademarks 150 2 Total intangible assets acquired $ 17,150 The fair value assigned to the developed technology was determined using the multi-period excess earnings method of the income approach. The fair value assigned to the customer relationships was determined using the distributor method under the income approach, which includes estimates of customer attrition rates. The intangible assets acquired are expected to be amortized over their useful lives on a straight-line basis. As part of the consideration transferred, we withheld 1,317,079 shares of our common stock with a fair value of $14.59 per share at the time of grant (Holdback Shares) and $0.4 million of cash related to certain obligations, including indemnification for potential breach of general representations and warranties of the sellers. The Holdback Shares and cash are expected to be released 18 months from the acquisition closing date, subject to claims for any obligations. In connection with the acquisition, we granted 1,315,099 shares of restricted common stock that vest over a period of two years contingent on continued employment, for which stock-based compensation expense will be recognized ratably over the vesting period. There was no other contingent consideration or cash consideration expected to be paid out subsequent to the acquisition. The results of operations of Scalyr have been included in our consolidated financial statements from the date of acquisition. We incurred $1.4 million of transaction costs in connection with the acquisition during fiscal 2022. These costs were recorded as general and administrative expenses in the consolidated statements of operations. The following unaudited pro forma financial information summarizes the results of operations of SentinelOne and Scalyr as if the acquisition occurred on February 1, 2020 (in thousands): Year Ended January 31, 2022 2021 Revenue $ 204,874 $ 101,875 Net loss $ (262,145) $ (171,321) Our consolidated statements of operations from the acquisition date to the period ended January 31, 2022 includes revenue and net income of Scalyr of $13.4 million and $0.2 million, respectively. The pro forma results reflect certain adjustments for the amortization of acquired intangible assets, adjustments to revenue resulting from the fair value adjustment to deferred revenue, recognition of stock-based compensation, and acquisition-related costs. Such pro forma amounts are not necessarily indicative of the results that actually would have occurred had the acquisition been completed on the date indicated, nor is it indicative of our future operating results.

Subsequent Events

Subsequent Events	12 Months Ended
	Jan. 31, 2022
Subsequent Events [Abstract]
Subsequent Events	SUBSEQUENT EVENTSOn March 15, 2022, we signed a definitive merger agreement to acquire 100% of the issued and outstanding equity securities of Attivo Networks, Inc. (Attivo), a leading identity security and lateral movement protection company. The aggregate consideration will be approximately 58% cash and approximately 42% in shares of our Class A common stock for a total consideration of $616.5 million, subject to adjustments. The number of shares to be issued in connection with the stock consideration will be based on a fixed value of $40.49 per share, which represents the average of the daily volume weighted average sales price of a share of our Class A common stock for the 30 consecutive trading days ending on March 14, 2022, subject to adjustments. This acquisition is expected to close in the second fiscal quarter of 2023, subject to regulatory approval and customary closing conditions.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	12 Months Ended
	Jan. 31, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America (GAAP). The consolidated financial statements include the accounts of SentinelOne and our wholly-owned subsidiaries. All intercompany balances and transactions have been eliminated in consolidation.
Fiscal Year	Fiscal Year Our fiscal year ends on January 31. References to fiscal 2022, 2021 and 2020 refer to the fiscal years ended January 31, 2022, January 31, 2021 and January 31, 2020, respectively.
Forward Stock Split	Forward Stock SplitOn February 6, 2020, we effected a one-to-three forward stock split of our issued and outstanding shares of common stock and redeemable convertible preferred stock. The par values of common stock and redeemable convertible preferred stock were not adjusted as a result of the stock split. All references to shares of common stock, options, warrants, and redeemable convertible preferred stock and per share amounts have been retroactively adjusted to reflect the forward stock split for the periods presented.
Use of Estimates	Use of Estimates The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes. These estimates include, but are not limited to, the valuation of our common stock prior to our IPO in June 2021, stock-based compensation, the period of benefit for deferred contract acquisition costs, standalone selling prices (SSP) for each performance obligation, useful lives of long-lived assets, the incremental borrowing rate (IBR) used for operating lease liabilities, and accounting for income taxes. Actual results could differ from those estimates.
Segment and Geographic Information	Segment and Geographic InformationWe have a single operating and reportable segment. Our chief operating decision maker (CODM) is our Chief Executive Officer. The CODM reviews financial information presented on a consolidated basis for purposes of making operating decisions, allocating resources, and assessing financial performance.
Foreign Currency	Foreign Currency During fiscal 2022, we changed the functional currency of certain subsidiaries from their respective local currency to the U.S. dollar. The change in functional currency is due to increased exposure to the U.S. dollar as a result of a change in facts and circumstances in the primary economic environment in which these subsidiaries operate. The effects of the change in functional currency were not significant to our consolidated financial statements. Subsequent to the change, our reporting currency and the functional currency of our foreign subsidiaries is the U.S. dollar. Foreign currency transaction gains and losses are recorded in other income (expense), net in the consolidated statements of operations and were not material for any periods presented.
Revenue	Revenue Recognition We recognize revenue in accordance with Accounting Standards Codification (ASC) 606, Revenue from Contracts with Customers. Revenue is recognized when a customer obtains control of promised services. The amount of revenue recognized reflects the consideration that we expect to be entitled to receive in exchange for the subscriptions and services. We apply the following five-step approach to recognize revenue: (i) Identification of the Contract, or Contracts, with the Customer —We determine that we have a contract with a customer when the contract is approved, the payment terms for the services can be identified, each party’s rights regarding the services to be transferred can be identified, the customer has the ability and intent to pay, and the contract has commercial substance. We apply judgment in determining the customer’s ability and intent to pay, which is based on a variety of factors, including the customer’s historical payment experience or, in the case of a new customer, credit and financial information of the customer. We sell through our indirect relationships with our channel partners or direct relationships with end customers through our internal sales force. Apart from certain sales arrangements where channel partners are determined to be our customers, we have concluded that the end customer is our customer. (ii) Identification of the Performance Obligations in the Contract —Performance obligations in a contract are identified based on the services that will be transferred to a customer that are both capable of being distinct, where the customer can benefit from the service either on its own or together with other resources that are readily available to the customer, and are distinct in the context of the contract, whereby the transfer of the services is separately identifiable from other promises in the contract. To the extent a contract includes multiple promised services, we apply judgment to determine whether promised services are capable of being distinct and distinct in the context of the contract. If these criteria are not met, the promised services are accounted for as a combined performance obligation. We have concluded that our contracts with customers do not contain warranties that give rise to a separate performance obligation. (iii) Determination of the Transaction Price —The transaction price is the amount of consideration we expect to be entitled from a customer in exchange for providing the subscriptions and services. Variable consideration is included in the transaction price if, in our judgment, it is probable that no significant future reversal of cumulative revenue under the contract will occur. Some of our end customers are entitled to receive service level commitment credits, in which we may be contractually obligated to provide partial refunds, and in rare instances, each representing a form of variable consideration. We have historically not experienced any significant incidents affecting the defined guarantees of performance levels or service response affecting the defined guarantees of performance levels or service response rates, and accordingly, estimated refunds related to service level commitment credits in the consolidated financial statements were not material during fiscal 2022, 2021 and 2020. None of our contracts contain a significant financing component. The transaction price excludes amounts collected on behalf of third parties, such as sales taxes. (iv) Allocation of the Transaction Price to the Performance Obligations in the Contract —If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on relative SSP. (v) Recognition of Revenue when, or as, Performance Obligations are Satisfied —Revenue is recognized when control of the related performance obligation is transferred to the customer in an amount that reflects the consideration expected to be received in exchange for the subscriptions or services. We generate substantially all of our revenue from subscriptions to our Singularity Platform. Our Singularity Platform delivers artificial intelligence-powered threat prevention, detection, and response capabilities, enabling an automatic protection against a full spectrum of cyber threats. We built our Singularity Platform to be deployed as a cloud service or in private and hybrid clouds. Customers can extend the functionality of their subscription to our platform by subscribing to additional Singularity Modules. The nature of our promise to the customer under the subscription is to stand ready to provide protection for the duration of the contractual term. As a result, we recognize revenue for these performance obligations ratably over the contractual term. Premium support and maintenance and other Singularity Modules are distinct from subscriptions and are recognized ratably over the term as the performance obligations are satisfied. We generally invoice our customers upfront upon signing for the entire term of the contract, periodically, or in arrears. Most of our subscription contracts have a term of one to three years. Our payment terms typically range between 30 to 45 days. The invoiced amounts are treated as deferred revenue on the consolidated balance sheets and are recognized ratably over the term of the contract beginning on the date the customer is given access to our platform. Our contracts are generally non-cancelable over the contractual term. Contracts with Multiple Performance Obligations Our contracts with customers may contain multiple promised services consisting of subscriptions to our Singularity Platform, premium support and maintenance, and other Singularity Modules that are distinct and accounted for separately. The transaction price is allocated to separate performance obligations on a relative SSP basis. Our best evidence for SSP is the price we charge for the subscription or service when we sell it separately in similar circumstances to similar customers. In instances where performance obligations do not have observable standalone sales, we utilize available information that may include, but is not limited to, product groupings or applying the expected cost-plus margin approach to estimate the price we would charge if the service was sold separately. Cost of Revenue Cost of revenue consists primarily of third-party cloud infrastructure expenses incurred in connection with the hosting and maintenance of our platform, personnel-related costs associated with our customer support and services organization, including salaries, benefits, bonuses, and stock-based compensation, amortization of capitalized internal-use software, software and subscription services used by our customer support and services team, and allocated overhead costs.
Research and Development	Research and Development Research and development costs are expensed as incurred, unless they qualify for recognition as capitalized internal-use software. Research and development expenses consist primarily of personnel-related costs, including salaries, benefits, bonuses, and stock-based compensation, consulting fees, software and subscription services, third-party cloud infrastructure expenses incurred in developing our platform and modules, and allocated overhead costs.
Advertising Expense	Advertising ExpensesAdvertising costs are expensed as incurred and included in sales and marketing expenses in the consolidated statements of operations.
Stock-Based Compensation	Stock-Based Compensation We account for stock-based awards issued to employees and directors based on the fair value of the awards at grant date. The fair value of stock option awards granted and rights to purchase shares under our employee stock purchase plan (ESPP) are generally estimated using the Black-Scholes option pricing model. Stock-based compensation expense for awards with only service-based vesting conditions is recognized on a straight-line basis over the requisite service period of the awards. Forfeitures are accounted for in the period in which they occur. We granted certain awards that have both a service-based and achievements of certain milestones. We recognize stock-based compensation expense on a graded basis over the total requisite service period for each separately vesting portion of the performance tranches related to these performance milestone options. We also granted stock option awards with a service-based, performance-based, and market-based vesting conditions to our Chief Executive Officer and Chief Financial Officer, These stock options will vest 100% upon the occurrence of our IPO (the performance-based vesting condition) and the achievement of certain milestone events and our share price targets (the market-based vesting conditions), subject to the executive’s continued service to us from the grant date through the milestone events. For these options, we used a Monte Carlo simulation to determine the fair value at the grant date and the implied service period. For these awards, stock-based compensation expense is recognized using the accelerated attribution method over the requisite implied service period when it is probable the performance-based vesting condition will be achieved.
Income Taxes	Income Taxes We are subject to income taxes in the United States and other foreign jurisdictions. We utilize the asset and liability method of accounting for income taxes whereby deferred tax assets and liabilities are determined based on differences between financial reporting and tax bases of assets and liabilities, as well as from net operating loss carryforwards, and are measured using the enacted tax rates and laws that will be in effect when the differences are expected to reverse. A valuation allowance is established if, based upon the available evidence, it is more likely than not that some or all of the deferred tax assets will not be realized. We consider all available evidence, both positive and negative, including historical levels of income, expectations, and risks associated with estimates of future taxable income in assessing the need for a valuation allowance.
Net Loss per Share Attributable to Common Stockholders	Net Loss per Share Attributable to Common Stockholders We compute basic and diluted net loss per share attributable to common stockholders using the two-class method required for participating securities. We consider our redeemable convertible preferred stock, restricted common stock, and shares issued upon the early exercise of stock options subject to repurchase to be participating securities. Under the two-class method, net loss is not allocated to redeemable convertible preferred stock, restricted common stock, and early exercised stock options as the holders do not have a contractual obligation to share in our losses.
Cash, Cash Equivalents, and Restricted Cash	Cash, Cash Equivalents, and Restricted Cash We consider all highly liquid investments purchased with an original maturity of three months or less at the time of purchase to be cash equivalents. Cash equivalents consist of amounts invested in money market funds. Restricted cash consists of collateralized letters of credit established in connection with lease agreements for our office facilities. Restricted cash, current and non-current, are included within prepaid expenses and other current assets and other assets, respectively, on our consolidated balance sheets.
Short-Term Investments and Strategic Investments	Short-Term Investments We determine the appropriate classification of our investments at the time of purchase and reevaluate such determination at each balance sheet date. We classify our investments as available-for-sale securities and present them within current assets as we may liquidate these investments at any time for use in our current operations or for any other purpose. Our investments are recorded at fair value with unrealized gains and losses, if any, reported in accumulated other comprehensive income (loss). Unrealized gains and losses and decline in value that are considered to be other-than-temporary are recognized in other income (expense), net in the consolidated statements of operations. We did not identify any investments with other-than-temporary impairments as of January 31, 2022 and 2021. Realized gains and losses on the sale of short-term investments are determined on a specific identification method and are recorded in other income (expense), net in the consolidated statements of operations. There were no realized gains or losses on the sale of short-term investments during fiscal 2022, 2021 and 2020. Strategic Investments Our strategic investments consist of non-marketable equity investments in privately held companies. We elect to apply the measurement alternative and record these investments at cost, less any impairment, plus or minus observable price changes in orderly transactions for identical or similar investments of the same issuer. Strategic investments are included within other assets on our consolidated balance sheets and adjustments to their carrying amounts are recorded in other income (expense), net in the consolidated statements of operations. There were no material events or circumstances impacting the carrying amount of our strategic investments during fiscal 2022, 2021 and 2020.
Deferred Contract Acquisition Costs and Deferred Offering Costs	Deferred Offering CostsPrior to the IPO, all deferred offering costs were capitalized in other assets on the consolidated balance sheets. Deferred Contract Acquisition CostsWe capitalize sales commissions and associated payroll taxes that are incremental to obtaining a customer contract, which are recorded as deferred contract acquisition costs on the consolidated balance sheets. Sales commissions for the renewal of a contract are not considered commensurate with commissions paid for the initial contracts, given the substantive difference in commission rates in proportion to their respective contract values. Commissions paid on a new contract are amortized on a straight-line basis over an estimated period of benefit of four years, while commissions paid on renewal contracts are amortized over the contractual term of the renewal. We determine the estimated period of benefit based on both quantitative and qualitative factors, including the duration of our relationships with customers and the estimated useful life of our technology. Amortization of deferred contract acquisition costs is included in sales and marketing expenses in the consolidated statements of operations.We periodically review these deferred contract acquisition costs to determine whether events or changes in circumstances have occurred that could impact the period of benefit.
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The carrying amounts reported on the consolidated balance sheets for cash equivalents, short-term investments, accounts receivable, accounts payable, accrued liabilities, and accrued payroll and benefits approximate their respective fair values due to their short-term nature.
Concentrations of Credit Risk	Concentrations of Credit RiskFinancial instruments that potentially subject us to concentrations of credit risk consist primarily of cash and cash equivalents, restricted cash, short-term investments, and accounts receivable. We maintain our cash, cash equivalents, restricted cash, and short-term investments with high-credit-quality financial institutions mainly in the U.S. and Israel. We have not experienced any credit losses relating to our cash, cash equivalents, restricted cash, and short-term investments. For accounts receivable, we are exposed to credit risk in the event of nonpayment by customers to the extent of the amounts recorded on the consolidated balance sheets. We perform periodic credit evaluations of our customers and generally do not require collateral.
Accounts Receivable	Accounts ReceivableAccounts receivable are recorded at invoiced amounts and are non-interest bearing. We have a well-established collection history from our channel partners and end customers. We periodically evaluate the collectability of our accounts receivable and provide an allowance for doubtful accounts as necessary, based on the age of the receivable, expected payment ability, and collection experience.
Property and Equipment	Property and Equipment Property and equipment are stated at cost, net of accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets as follows: Estimated Useful Life Office furniture and equipment 5 years Computers, software, and electronic equipment 3 years Capitalized internal-use software 4 years Leasehold improvements Shorter of useful life or remaining term of lease Costs for maintenance and repairs are expensed as incurred.
Capitalized Internal-Use Software	Capitalized Internal-Use Software We capitalize certain internal-use software development costs related to our cloud platform. Costs incurred in the preliminary stages of development and post-development are expensed as incurred. Internal and external costs incurred during the development phase, if direct, are capitalized until the software is substantially complete and ready for our intended use. We also capitalize costs related to specific upgrades and enhancements when it is probable the expenditures will result in additional functionality. Maintenance and training costs are expensed as incurred. Capitalized internal-use software is included in property and equipment and is amortized to cost of revenue on a straight-line basis over its expected useful life.
Impairment of Long-Lived Assets (Including Goodwill and Intangible Assets	Impairment of Long-Lived Assets (Including Goodwill and Intangible Assets) Long-lived assets, including intangible assets with finite lives, are reviewed for impairment when events or changes in circumstances indicate that the carrying amount of asset may not be recoverable. Recoverability of assets is measured by a comparison of the carrying amount of an asset to the future undiscounted cash flows expected to be generated by the asset. If such assets are considered to be impaired, the impairment to be recognized is measured by the amount by which the carrying amount of the assets exceeds the fair value of the asset group. No impairment loss was recorded during fiscal 2022, 2021 and 2020. Goodwill is not amortized but tested for impairment at least annually in the fourth quarter, or more frequently if events or changes in circumstances indicate that impairment may exist. The impairment test consists of a qualitative assessment to determine if the quantitative assessment is required. Goodwill impairment is recognized when the quantitative assessment results in the carrying value of the reporting unit exceeding its fair value, net of related income tax effect, in which case an impairment charge is recorded to goodwill to the extent the carrying value exceeds the fair value, limited to the amount of goodwill. We did not recognize any impairment of goodwill during fiscal 2022.
Business Combinations	Business Combinations We account for our acquisitions using the acquisition method of accounting. We allocate the fair value of purchase consideration to the tangible and intangible assets acquired, and liabilities assumed, based on their estimated fair values. The excess of the fair value of purchase consideration over the values of these identifiable assets and liabilities is recorded as goodwill. When determining the fair value of assets acquired and liabilities assumed, management makes significant estimates and assumptions, especially with respect to intangible assets. Significant estimates in valuing certain identifiable assets include, but are not limited to, the selection of valuation methodologies, future expected cash flows, discount rates, and useful lives. Management’s estimates of fair value are based upon assumptions believed to be reasonable, but which are inherently uncertain and unpredictable and, as a result, actual results may differ from estimates. Acquisition costs, such as legal and consulting fees, are expensed as incurred and are included in general and administrative expenses in the consolidated statements of operations. During the measurement period, which is up to one year from the acquisition date, we may record adjustments to the assets acquired and liabilities assumed, with the corresponding offset to goodwill. Upon the conclusion of the measurement period, any subsequent adjustments are recorded in the consolidated statements of operations. See Note 17 for additional information regarding our acquisitions.
Leases	Leases In accordance with ASC 842, we determine if an arrangement is or contains a lease at inception by evaluating various factors, including if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration and other facts and circumstances. Operating lease right-of-use (ROU) assets and operating lease liabilities are recognized on the consolidated balance sheets at the lease commencement date based on the present value of lease payments over the lease term, which is the non-cancelable period stated in the contract adjusted for any options to extend or terminate the lease when it is reasonably certain that we will exercise that option. Lease payments consist of the fixed payments under the arrangement, less any lease incentives, such as tenant improvement allowances. Variable costs, such as maintenance and utilities based on actual usage, are not included in the measurement of operating lease ROU assets and operating lease liabilities and are expensed when the event determining the amount of variable consideration to be paid occurs. When the implicit rate of the leases is not determinable, we use an IBR based on the information available at the lease commencement date in determining the present value of lease payments. Lease cost for lease payments is recognized on a straight-line basis over the lease term. We account for lease components and non-lease components as a single lease component. In addition, we do not recognize operating lease ROU assets and operating lease liabilities for leases with lease terms of 12 months or less. In addition, we sublease certain of our unoccupied facilities to third parties. We recognize sublease income on a straight-line basis over the sublease term.
Recently Adopted Accounting Pronouncements and Recent Accounting Pronouncements Not Yet Adopted	Recently Adopted Accounting Pronouncement s In December 2019, the Financial Accounting Standards Board (FASB) issued Accounting Standards Update (ASU) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes . This guidance simplifies the accounting for income taxes by eliminating certain exceptions to the guidance in Topic 740 related to the approach for intraperiod tax allocation, the methodology for calculating income taxes in an interim period, and the recognition of deferred tax liabilities for outside basis differences. The guidance also simplifies aspects of the accounting for franchise taxes and enacted changes in tax laws or rates, and clarifies the accounting for transactions that result in a step-up in the tax basis of goodwill and the allocation of consolidated income taxes to separate financial statements of entities not subject to income tax. We early adopted this guidance on August 1, 2021, which did not have a material impact on our consolidated financial statements. In January 2017, the FASB issued ASU No. 2017-04, Intangibles—Goodwill and Other (Topic 350): Simplifying the Test for Goodwill Impairment . This ASU simplifies the measurement of goodwill by eliminating step two of the two-step impairment test. Step two measures a goodwill impairment loss by comparing the implied fair value of a reporting unit’s goodwill with the carrying amount of that goodwill. This ASU requires an entity to compare the fair value of a reporting unit with its carrying amount and recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit’s fair value. Additionally, an entity should consider income tax effects from any tax-deductible goodwill on the carrying amount of the reporting unit when measuring the goodwill impairment loss, if applicable. We adopted this guidance on February 1, 2021, which did not have a material impact on our consolidated financial statements. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments , which provides new authoritative guidance with respect to the measurement of credit losses on financial instruments. This update changes the impairment model for most financial assets and certain other instruments by introducing a current expected credit loss (CECL) model. The CECL model is a more forward-looking approach based on expected losses rather than incurred losses, requiring entities to estimate and record losses expected over the remaining contractual life of an asset. We adopted this guidance on February 1, 2021, which did not have a material impact on our consolidated financial statements. Recent Accounting Pronouncements Not Yet Adopted In October 2021, the FASB issued ASU No. 2021-08, Business Combinations (Topic 805): Accounting for Contract Assets and Contract Liabilities from Contracts with Customers . The new guidance requires contract assets and contract liabilities acquired in a business combination to be recognized in accordance with Accounting Standards Codification (ASC) Topic 606 as if the acquirer had originated the contracts. The guidance is effective for us on February 1, 2023. We are currently evaluating the impact of this guidance on our consolidated financial statements. In August 2020, the FASB issued ASU No. 2020-06, Debt—Debt with Conversion and Other Options (Subtopic 470-20) and Derivatives and Hedging—Contracts in Entity’s Own Equity (Subtopic 815-40): Accounting for Convertible Instruments and Contracts in an Entity’s Own Equity

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	12 Months Ended
	Jan. 31, 2022
Accounting Policies [Abstract]
Schedule of Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the consolidated statements of cash flows (in thousands): As of January 31, 2022 2021 Cash and cash equivalents $ 1,669,304 $ 395,472 Restricted cash, current — 946 Restricted cash, non-current 2,747 2,694 $ 1,672,051 $ 399,112
Restrictions on Cash and Cash Equivalents	The following table provides a reconciliation of cash, cash equivalents, and restricted cash to the total of these amounts shown in the consolidated statements of cash flows (in thousands): As of January 31, 2022 2021 Cash and cash equivalents $ 1,669,304 $ 395,472 Restricted cash, current — 946 Restricted cash, non-current 2,747 2,694 $ 1,672,051 $ 399,112
Schedules of Concentration of Risk, by Risk Factor	The only channel partner that represented 10% or more of accounts receivable, net for the periods presented was as follows: As of January 31, 2022 2021 Channel partner A 18 % 23 % Channel partners that represented 10% or more of our total revenue for the periods presented were as follows: Year Ended January 31, 2022 2021 2020 Channel partner A 18 % 19 % 19 % Channel partner B * 13 % 14 % *Less than 10%
Property and Equipment	Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets as follows: Estimated Useful Life Office furniture and equipment 5 years Computers, software, and electronic equipment 3 years Capitalized internal-use software 4 years Leasehold improvements Shorter of useful life or remaining term of lease Property and equipment, net consisted of the following (in thousands): As of January 31, 2022 2021 Office furniture and equipment $ 1,318 $ 837 Computers, software, and electronic equipment 4,895 3,489 Capitalized internal-use software 17,917 6,959 Leasehold improvements 7,490 4,568 Construction in progress 3,108 2,925 Total property and equipment 34,728 18,778 Less: Accumulated depreciation and amortization (9,810) (5,405) Total property and equipment, net $ 24,918 $ 13,373

Revenue and Contract Balances (

Revenue and Contract Balances (Tables)	12 Months Ended
	Jan. 31, 2022
Revenue from Contract with Customer [Abstract]
Revenue from External Customers by Geographic Areas	The following table summarizes revenue by geography based on the shipping address of end customers who have contracted to use our platform for the periods presented (in thousands, except percentages): Year Ended January 31, 2022 2021 2020 Amount % of Revenue Amount % of Revenue Amount % of Revenue United States $ 140,034 68 % $ 65,497 70 % $ 33,972 73 % International 64,765 32 27,559 30 12,502 27 Total $ 204,799 100 % $ 93,056 100 % $ 46,474 100 %
Disaggregation of Revenue	The following table summarizes revenue from contracts by type of customer for the periods presented (in thousands, except percentages): Year Ended January 31, 2022 2021 2020 Amount % of Revenue Amount % of Revenue Amount % of Revenue Channel partners $ 187,541 92 % $ 88,954 96 % $ 42,881 92 % Direct customers 17,258 8 4,102 4 $ 3,593 8 Total $ 204,799 100 % $ 93,056 100 % $ 46,474 100 %

Fair Value Measurements (Tables

Fair Value Measurements (Tables)	12 Months Ended
	Jan. 31, 2022
Fair Value Disclosures [Abstract]
Fair Value, Assets Measured on Recurring Basis	The following table summarizes the respective fair value and the classification by level within the fair value hierarchy (in thousands): As of January 31, 2022 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 1,641,642 $ — $ — $ 1,641,642 Short-term investments: Certificates of deposit — 375 — 375 Total assets measured and recorded at fair value $ 1,641,642 $ 375 $ — $ 1,642,017 As of January 31, 2021 Level 1 Level 2 Level 3 Total Assets Cash equivalents: Money market funds $ 40,518 $ — $ — $ 40,518 Short-term investments: Certificates of deposit — 364 — 364 Total assets measured and recorded at fair value $ 40,518 $ 364 $ — $ 40,882

Property and Equipment, Net (Ta

Property and Equipment, Net (Tables)	12 Months Ended
	Jan. 31, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment, Net	Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the assets as follows: Estimated Useful Life Office furniture and equipment 5 years Computers, software, and electronic equipment 3 years Capitalized internal-use software 4 years Leasehold improvements Shorter of useful life or remaining term of lease Property and equipment, net consisted of the following (in thousands): As of January 31, 2022 2021 Office furniture and equipment $ 1,318 $ 837 Computers, software, and electronic equipment 4,895 3,489 Capitalized internal-use software 17,917 6,959 Leasehold improvements 7,490 4,568 Construction in progress 3,108 2,925 Total property and equipment 34,728 18,778 Less: Accumulated depreciation and amortization (9,810) (5,405) Total property and equipment, net $ 24,918 $ 13,373

Intangible Assets (Tables)

Intangible Assets (Tables)	12 Months Ended
	Jan. 31, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible assets, net as of January 31, 2022 consisted of the following (in thousands): As of January 31, 2022 Developed technology $ 15,500 Customer relationship 1,500 Non-compete agreements 650 Trademarks 150 Patents 1,094 Total finite-lived intangible assets 18,894 Less: accumulated amortization (3,342) Total finite-lived intangible assets, net $ 15,552 Indefinite-lived intangible assets - domain names $ 255 Total intangible assets, net $ 15,807
Schedule of Finite-Lived Intangible Assets, Future Amortization Expense	As of January 31, 2022, estimated future amortization expense is as follows (in thousands): Fiscal Year Ending January 31, 2023 3,381 2024 2,578 2025 2,353 2026 2,341 2027 2,341 Thereafter 2,558 Total $ 15,552

Leases (Tables)

Leases (Tables)	12 Months Ended
	Jan. 31, 2022
Leases [Abstract]
Lease, Cost	Supplemental cash flow information related to our operating leases for fiscal 2022 and 2021 as well as the weighted-average remaining lease term and weighted-average discount rate as of January 31, 2022 and 2021 were as follows: Year Ended January 31, 2022 2021 Supplemental Cash Flow Information Cash paid for amount included in the measurement of operating lease liabilities $ 4,596 $ 3,999 Operating lease ROU assets obtained in exchange for operating lease liabilities $ 8,558 $ 6,579 As of January 31, 2022 2021 Lease Term and Discount Rate Weighted-average remaining lease term (years) 6.56 7.42 Weighted-average discount rate 4.3 % 4.3 % The components of lease costs consisted of the following (in thousands): Year Ended January 31, 2022 2021 Operating lease costs $ 4,027 $ 3,844 Short-term lease costs 2,248 509 Variable lease costs 1,124 702 Total lease costs $ 7,399 $ 5,055
Lessee, Operating Lease, Liability, Maturity	The maturities of our non-cancelable operating lease liabilities as of January 31, 2022 were as follows (in thousands): Fiscal Year Ending January 31, Amount 2023 4,926 2024 5,188 2025 5,109 2026 5,168 2027 5,229 Thereafter 7,845 Total operating lease payments $ 33,465 Less: Imputed interest (4,385) Present value of operating lease liabilities $ 29,080

Preferred Stock (Tables)

Preferred Stock (Tables)	12 Months Ended
	Jan. 31, 2022
Equity [Abstract]
Temporary Equity	Our redeemable convertible preferred stock as of January 31, 2021 consisted of the following (in thousands, except share and per share data): As of January 31, 2021 Shares Authorized Shares Issued and Outstanding Liquidation Amount Carrying Value Original Issuance Price per Share Series Seed 10,962,327 10,962,327 $ 2,577 $ 2,553 $ 0.2351 Series A 12,855,123 12,855,123 10,000 9,948 0.7779 Series B 20,288,700 20,288,700 24,338 24,241 1.1996 Series C 40,338,867 40,338,867 70,433 69,845 1.7460 Series D 29,078,931 29,078,931 95,476 95,239 3.2833 Series E 31,405,183 31,405,183 152,683 152,539 4.8617 Series F 24,056,282 22,128,982 266,907 266,774 12.0614 Total 168,985,413 167,058,113 $ 622,414 $ 621,139

Common Stock (Tables)

Common Stock (Tables)	12 Months Ended
	Jan. 31, 2022
Equity [Abstract]
Schedule Of Common Stock Reserved For Future Issuance	Our common stock reserved for future issuance on an as-converted basis as of January 31, 2022 and 2021 were as follows: As of January 31, 2022 2021 Conversion of redeemable convertible preferred stock — 168,951,059 Exercise of common stock warrants — 954,884 Stock options outstanding 42,422,473 37,231,191 RSUs outstanding 1,770,304 — ESPP reserved for future issuance 6,674,603 — 2021 Plan available for future grants 38,055,572 5,642,142 Total shares of common stock reserved 88,922,952 212,779,276

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	12 Months Ended
	Jan. 31, 2022
Share-based Payment Arrangement [Abstract]
Nonvested Restricted Stock Shares Activity	A summary of our RSUs under the 2021 Plan is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2021 — $ — Granted 1,491,253 $ 57.17 Released (11,902) $ 62.60 Forfeited (41,998) $ 54.29 Outstanding as of January 31, 2022 1,437,353 $ 57.21 A summary of our RSUs under the 2013 Plan is as follows: Number of Shares Weighted-Average Grant Date Fair Value Outstanding as of January 31, 2021 — $ — Granted 346,483 $ 32.39 Released (3,316) $ 32.69 Forfeited (10,216) $ 32.48 Outstanding as of January 31, 2022 332,951 $ 32.38
Share-based Payment Arrangement, Option, Activity	A summary of our stock option plan activity under the 2013 Plan is as follows: Number of Options Weighted-Average Exercise Price Weighted-Average Remaining Contractual Term (in years) Aggregate Intrinsic Value (in thousands) Outstanding as of January 31, 2021 37,231,191 $ 1.68 8.34 $ 442,515 Granted 14,048,623 $ 9.66 Exercised (8,406,950) $ 1.52 Forfeited (1,131,723) $ 3.34 Outstanding as of January 31, 2022 41,741,141 $ 4.34 7.95 $ 1,686,738 Expected to vest as of January 31, 2022 41,741,141 $ 4.34 7.95 $ 1,686,738 Vested and exercisable as of January 31, 2022 17,467,223 $ 2.47 7.16 $ 738,584
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions	Year Ended January 31, 2022 2021 Expected term (in years) 6.0 6.0 Expected volatility 62.3% - 66.0% 47.3% - 48.7% Risk-free interest rate 0.8% - 1.1% 0.4% - 0.6% Dividend yield — % — %
Schedule of Components of Stock-based Compensation Expense	The components of stock-based compensation expense recognized in the consolidated statements of operations consisted of the following (in thousands): Year Ended January 31, 2022 2021 Cost of revenue $ 3,618 $ 308 Research and development 35,358 6,590 Sales and marketing 15,460 3,835 General and administrative 33,453 5,179 Total $ 87,889 $ 15,912
Schedule of Share-based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions	The following table summarizes assumptions used in estimating the fair value of employee stock purchase rights for the initial and second offering period under the 2021 ESPP using the Black-Scholes option pricing model: Year Ended Expected term (in years) 0.5 - 2 Expected volatility 52.3% - 70.5% Risk-free interest rate 0.1% - 0.3% Dividend yield — %

Income Taxes (Tables)

Income Taxes (Tables)	12 Months Ended
	Jan. 31, 2022
Income Tax Disclosure [Abstract]
Schedule of Income before Income Tax, Domestic and Foreign	Our loss before provision for income taxes for fiscal 2022, 2021 and 2020 consisted of the following (in thousands) : Year Ended January 31, 2022 2021 2020 Domestic $ (274,270) $ (18,159) $ (1,700) Foreign 4,173 (98,954) (74,630) Loss before provision for income taxes $ (270,097) $ (117,113) $ (76,330)
Schedule of Components of Income Tax Expense (Benefit)	The components of provision for income taxes for fiscal 2022, 2021, and 2020 consisted of the following (in thousands): Year Ended January 31, 2022 2021 2020 Current: State 82 62 52 Foreign 1,011 398 185 Total current 1,093 460 237 Deferred: Foreign (89) — — Total deferred (89) — — Total provision for income taxes $ 1,004 $ 460 $ 237
Schedule of Effective Income Tax Rate Reconciliation	A reconciliation of the expected provision for (benefit from) income taxes at the statutory federal income tax rate to our recorded provision for income taxes consisted of the following (in thousands): Year Ended January 31, 2022 2021 2020 Benefit from income taxes at U.S. federal statutory rate $ (56,720) $ (24,594) $ (16,029) State taxes, net of federal benefit 82 49 41 Foreign tax rate differential (1,297) (1,836) (6,852) Stock-based compensation (23,442) 1,195 771 Non-deductible expenses 322 84 109 Change in valuation allowance 81,739 25,564 22,857 Other 320 (2) (660) Total provision for income taxes $ 1,004 $ 460 $ 237
Schedule of Deferred Tax Assets and Liabilities	Significant components of our net deferred tax assets and liabilities as of January 31, 2022 and 2021 consisted of the following (in thousands): As of January 31, 2022 2021 Deferred tax assets: Net operating loss carryforwards $ 174,646 $ 70,735 Research and development expenses 36,989 11,479 Accruals and reserves 18,708 12,986 Operating lease liabilities 11,158 5,416 Stock-based compensation 7,936 140 Other 2,012 532 Gross deferred tax assets 251,449 101,288 Valuation allowance (218,981) (86,032) Total deferred tax assets 32,468 15,256 Deferred tax liabilities: Acquired intangibles, property and equipment (6,235) (1,217) Deferred contract acquisition costs (16,722) (9,697) Operating lease right-of-use assets (9,422) (4,342) Total deferred tax liabilities (32,379) (15,256) Net deferred tax assets $ 89 $ —

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable To Common Stockholders (Tables)	12 Months Ended
	Jan. 31, 2022
Earnings Per Share [Abstract]
Schedule of Earnings Per Share, Basic and Diluted	Basic and diluted net loss per share attributable to common stockholders was as follows (in thousands, except share and per share data): Year Ended January 31, 2022 2021 2020 Numerator: Net loss attributable to Class A and Class B common stockholders $ (271,101) $ (117,573) $ (76,567) Denominator: Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic and diluted 174,051,203 35,482,444 32,712,350 Net loss per share attributable to Class A and Class B common stockholders, basic and diluted $ (1.56) $ (3.31) $ (2.34)
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share	The following potentially dilutive securities were excluded from the computation of diluted net loss per share attributable to common stockholders because their inclusion would have been anti-dilutive: As of January 31, 2022 2021 2020 Redeemable convertible preferred stock — 168,951,059 113,523,948 Stock options 42,422,473 37,231,191 26,892,219 Common stock warrants — 954,884 1,276,686 Shares subject to repurchase 20,091 37,500 42,500 RSUs 1,770,304 — — ESPP 52,381 — — Restricted common stock 1,142,496 — — Contingently issuable shares 1,317,079 — — Total 46,724,824 207,174,634 141,735,353

Geographic Information (Tables)

Geographic Information (Tables)	12 Months Ended
	Jan. 31, 2022
Segment Reporting [Abstract]
Long-lived Assets by Geographic Areas	Long-lived assets, consisting of property and equipment, net, and operating lease right-of-use assets, by geography were as follows (in thousands): As of January 31, 2022 2021 United States $ 21,176 $ 10,386 Israel 26,646 20,987 Rest of world 980 26 Total $ 48,802 $ 31,399

Acquisitions (Tables)

Acquisitions (Tables)	12 Months Ended
	Jan. 31, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Recognized Identified Assets Acquired and Liabilities Assumed	The assets acquired and liabilities assumed in connection with the acquisition were recorded at their fair value on the date of acquisition as follows (in thousands): Amount Cash and cash equivalents $ 699 Accounts receivable 3,665 Restricted cash 444 Prepaid expense 277 Intangible assets 17,150 Goodwill 108,193 Accounts payable (412) Deferred revenue (5,041) Other liabilities (347) Total purchase consideration $ 124,628
Schedule of Finite-Lived Intangible Assets Acquired as Part of Business Combination	The following table sets forth the amounts allocated to the intangible assets identified and their estimated useful lives as of the date of acquisition: Fair Value Useful Life (in thousands) (in years) Developed technology $ 15,500 7 Customer relationships 1,500 2 Trademarks 150 2 Total intangible assets acquired $ 17,150
Business Acquisition, Pro Forma Information	The following unaudited pro forma financial information summarizes the results of operations of SentinelOne and Scalyr as if the acquisition occurred on February 1, 2020 (in thousands): Year Ended January 31, 2022 2021 Revenue $ 204,874 $ 101,875 Net loss $ (262,145) $ (171,321)

Organization and Description _2

Organization and Description of Business (Details) - USD ($) $ / shares in Units, $ in Billions	1 Months Ended
	Jul. 31, 2021	Jan. 31, 2022	Jul. 01, 2021	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2019
Class of Stock [Line Items]
Share price (in USD per share)	$ 35	$ 35
Sale of stock, consideration received on transaction	$ 1.4
Redeemable convertible preferred stock, shares outstanding (in shares)		0		167,058,113	113,523,948	97,686,390
Class A Common Stock
Class of Stock [Line Items]
Sale of stock, number of shares issued in transaction (in shares)	41,678,568
Redeemable convertible preferred stock
Class of Stock [Line Items]
Redeemable convertible preferred stock, shares outstanding (in shares)			167,058,113
Class B Common Stock
Class of Stock [Line Items]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	169,787,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, not on a one-for-one basis (in shares)	34,134,270
Series E
Class of Stock [Line Items]
Redeemable convertible preferred stock, shares outstanding (in shares)			31,405,183	31,405,183
Over-Allotment Option
Class of Stock [Line Items]
Sale of stock, number of shares issued in transaction (in shares)	5,250,000
Private Placement
Class of Stock [Line Items]
Sale of stock, number of shares issued in transaction (in shares)	1,428,568

Summary of Significant Accoun_4

Summary of Significant Accounting Policies - Narrative (Details) $ in Millions	Feb. 06, 2021	Jan. 31, 2022USD ($)	Jan. 31, 2021USD ($)	Jan. 31, 2020USD ($)	Jun. 30, 2021USD ($)
Accounting Policies [Abstract]
Stock split ratio	0.3333
Advertising expense		$ 7.8	$ 6.2	$ 4.2
Deferred offering costs					$ 7.6
Capitalized contract cost, amortization period		4 years

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Summary of Cash, Cash Equivalents, and Restricted Cash (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2019
Accounting Policies [Abstract]
Cash and cash equivalents	$ 1,669,304	$ 395,472
Restricted cash, current	0	946
Restricted cash, non-current	2,747	2,694
Cash, cash equivalents, restricted cash and restricted cash equivalents	$ 1,672,051	$ 399,112	$ 47,680	$ 42,485

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Concentration Risk Accounts Receivable (Details)	Jul. 31, 2021	Jan. 31, 2021
Accounts Receivable | Customer Concentration Risk | Channel partner A
Concentration Risk [Line Items]
Percentage of Accounts Receivable	18.00%	23.00%

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Concentration Risk Revenue (Details) - Revenue from Contract with Customer Benchmark - Customer Concentration Risk	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Channel partner A
Concentration Risk [Line Items]
% of Revenue	18.00%	19.00%	19.00%
Channel partner B
Concentration Risk [Line Items]
% of Revenue		13.00%	14.00%

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Property and Equipment (Details)	12 Months Ended
	Jan. 31, 2022
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life	5 years
Computers, software, and electronic equipment
Property, Plant and Equipment [Line Items]
Estimated Useful Life	3 years
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Estimated Useful Life	4 years

Revenue and Contract Balances -

Revenue and Contract Balances - Disaggregation of Revenue by Geography (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 204,799	$ 93,056	$ 46,474
Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Revenue	100.00%	100.00%	100.00%
United States
Disaggregation of Revenue [Line Items]
Revenue	$ 140,034	$ 65,497	$ 33,972
United States | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Revenue	68.00%	70.00%	73.00%
International
Disaggregation of Revenue [Line Items]
Revenue	$ 64,765	$ 27,559	$ 12,502
International | Revenue from Contract with Customer Benchmark | Geographic Concentration Risk
Disaggregation of Revenue [Line Items]
% of Revenue	32.00%	30.00%	27.00%

Revenue and Contract Balances_2

Revenue and Contract Balances - Disaggregation of Revenue by Type of Customer (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Disaggregation of Revenue [Line Items]
Revenue	$ 204,799	$ 93,056	$ 46,474
% of Revenue	100.00%	100.00%	100.00%
Channel partners
Disaggregation of Revenue [Line Items]
Revenue	$ 187,541	$ 88,954	$ 42,881
% of Revenue	92.00%	96.00%	92.00%
Direct customers
Disaggregation of Revenue [Line Items]
Revenue	$ 17,258	$ 4,102	$ 3,593
% of Revenue	8.00%	4.00%	8.00%

Revenue and Contract Balances_3

Revenue and Contract Balances - Narrative (Details) - USD ($)	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Disaggregation of Revenue [Line Items]
Unbilled receivables, current	$ 1,500,000	$ 1,500,000
Contract with customer, liability	262,000,000	141,800,000
Contract with customer, liability, revenue recognized	95,500,000	53,800,000	$ 25,900,000
Capitalized contract cost, impairment loss	$ 0	$ 0	$ 0
Minimum
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, contract term	1 year
Maximum
Disaggregation of Revenue [Line Items]
Revenue from contract with customer, contract term	3 years

Revenue and Contract Balances_4

Revenue and Contract Balances - Remaining Performance Obligations Narrative (Details) $ in Millions	Jan. 31, 2022USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, amount	$ 345.4
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-02-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Revenue, remaining performance obligation, percentage	90.00%
Revenue, remaining performance obligation, expected timing of satisfaction, period	24 months

Fair Value Measurements (Detail

Fair Value Measurements (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021
Short-term investments:
Short-term investments	$ 374	$ 364
Total assets measured and recorded at fair value	1,642,017	40,882
Level 1
Short-term investments:
Total assets measured and recorded at fair value	1,641,642	40,518
Level 2
Short-term investments:
Total assets measured and recorded at fair value	375	364
Level 3
Short-term investments:
Total assets measured and recorded at fair value	0	0
Certificates of deposit
Short-term investments:
Short-term investments	375	364
Certificates of deposit | Level 1
Short-term investments:
Short-term investments	0	0
Certificates of deposit | Level 2
Short-term investments:
Short-term investments	375	364
Certificates of deposit | Level 3
Short-term investments:
Short-term investments	0	0
Money market funds
Cash equivalents:
Money market funds	1,641,642	40,518
Money market funds | Level 1
Cash equivalents:
Money market funds	1,641,642	40,518
Money market funds | Level 2
Cash equivalents:
Money market funds	0	0
Money market funds | Level 3
Cash equivalents:
Money market funds	$ 0	$ 0

Fair Value Measurements - Narra

Fair Value Measurements - Narrative (Details) - USD ($)	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Fair Value Disclosures [Abstract]
Debt securities, available-for-sale, unrealized gain (loss)	$ 0	$ 0
Equity securities without readily determinable fair value, amount	$ 6,000,000
Non-marketable equity investments		$ 0

Property and Equipment, Net - S

Property and Equipment, Net - Summary of Property and Equipment (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 34,728	$ 18,778
Less: Accumulated depreciation and amortization	(9,810)	(5,405)
Property and equipment, net	24,918	13,373
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	1,318	837
Computers, software, and electronic equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	4,895	3,489
Capitalized internal-use software
Property, Plant and Equipment [Line Items]
Total property and equipment	17,917	6,959
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	7,490	4,568
Construction in progress
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 3,108	$ 2,925

Property and Equipment, Net - N

Property and Equipment, Net - Narrative (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Property, Plant and Equipment [Line Items]
Capitalized internal-use software costs	$ 10,600	$ 2,800	$ 1,700
Depreciation and amortization	7,909	2,837	1,855
Capitalized computer software, amortization	2,100	1,300	700
Property, Plant and Equipment
Property, Plant and Equipment [Line Items]
Depreciation and amortization	$ 4,600	$ 2,800	$ 1,900

Intangible Assets - Schedule of

Intangible Assets - Schedule of Intangible Assets, Net (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Developed technology	$ 15,500
Customer relationship	1,500
Non-compete agreements	650
Trademarks	150
Patents	1,094
Total finite-lived intangible assets	18,894
Less: accumulated amortization	(3,342)
Total finite-lived intangible assets, net	15,552
Indefinite-lived intangible assets - domain names	255
Intangible assets, net	$ 15,807	$ 470

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($)	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization of intangible assets	$ 3,300,000	$ 0	$ 0

Intangible Assets - Amortizatio

Intangible Assets - Amortization Expense (Details) $ in Thousands	Jan. 31, 2022USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]
2023	$ 3,381
2024	2,578
2025	2,353
2026	2,341
2027	2,341
Thereafter	2,558
Total finite-lived intangible assets, net	$ 15,552

Long-Term Debt (Details)

Long-Term Debt (Details) - USD ($)	Jul. 01, 2021	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020	May 31, 2020	May 31, 2018
Debt Instrument [Line Items]
Class of warrant or right, exercise price of warrants or rights (in USD per share)						$ 0.62
Class of warrant or right, outstanding (in shares)		0	954,884
Interest expense, long-term debt		$ 400,000	$ 1,400,000	$ 2,000,000
Class B Common Stock
Debt Instrument [Line Items]
Issuance of common stock upon exercise of warrants (in shares)	940,953
Loan and Security Agreement
Debt Instrument [Line Items]
Class of warrant or right, outstanding (in shares)		954,884
Revolving Credit Facility | Amended Line of Credit
Debt Instrument [Line Items]
Line of credit facility, maximum borrowing capacity					$ 45,000,000

Leases - Supplemental Cash Flow

Leases - Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Supplemental Cash Flow Information
Cash paid for amount included in the measurement of operating lease liabilities	$ 4,596	$ 3,999
Operating lease ROU assets obtained in exchange for operating lease liabilities	$ 8,558	$ 6,579

Leases - Lease Term and Discoun

Leases - Lease Term and Discount Rate (Details)	Jan. 31, 2022	Jan. 31, 2021
Lease Term and Discount Rate
Weighted-average remaining lease term (years)	6 years 6 months 21 days	7 years 5 months 1 day
Weighted-average discount rate	4.30%	4.30%

Leases - Components of Lease Co

Leases - Components of Lease Costs (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Leases [Abstract]
Operating lease costs	$ 4,027	$ 3,844
Short-term lease costs	2,248	509
Variable lease costs	1,124	702
Total lease costs	$ 7,399	$ 5,055

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Millions	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Leases [Abstract]
Sublease income	$ 0.6	$ 0.9	$ 1
Lessee, operating lease, lease not yet commenced, undiscounted amount	$ 3.6
Lessee, operating lease, lease not yet commenced, term of contract	6 years

Leases - Maturities (Details)

Leases - Maturities (Details) $ in Thousands	Jan. 31, 2022USD ($)
Leases [Abstract]
2023	$ 4,926
2024	5,188
2025	5,109
2026	5,168
2027	5,229
Thereafter	7,845
Total operating lease payments	33,465
Less: Imputed interest	(4,385)
Present value of operating lease liabilities	$ 29,080

Preferred Stock - Narrative (De

Preferred Stock - Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	1 Months Ended	12 Months Ended
	Jul. 31, 2021	Jan. 31, 2022	Jan. 31, 2021	Jul. 01, 2021	Jan. 31, 2020	Jan. 31, 2019
Temporary Equity [Line Items]
Redeemable convertible preferred stock, shares outstanding (in shares)		0	167,058,113		113,523,948	97,686,390
Preferred stock, shares authorized (in shares)		50,000,000	0
Preferred stock, par or stated value per share (in USD per share)		$ 0.0001	$ 0.0001
Preferred stock, shares outstanding (in shares)		0	0
Redeemable convertible preferred stock
Temporary Equity [Line Items]
Redeemable convertible preferred stock, shares outstanding (in shares)				167,058,113
Class B Common Stock
Temporary Equity [Line Items]
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)	169,787,200
Conversion of redeemable convertible preferred stock to common stock upon initial public offering, not on a one-for-one basis (in shares)	34,134,270
Series E
Temporary Equity [Line Items]
Redeemable convertible preferred stock, shares outstanding (in shares)			31,405,183	31,405,183
Issuance of Preferred Stock, net of issuance costs (in shares)		31,405,183	31,405,183
Original issuance price per share (in USD per share)		$ 4.8617	$ 4.8617
Proceeds from issuance of Series E redeemable convertible preferred stock, net of issuance costs		$ 152.5
Temporary equity, issuance costs		$ 0.1
Series F
Temporary Equity [Line Items]
Redeemable convertible preferred stock, shares outstanding (in shares)			22,128,982
Issuance of Preferred Stock, net of issuance costs (in shares)		22,128,982	22,128,982
Original issuance price per share (in USD per share)		$ 12.0614	$ 12.0614
Proceeds from issuance of Series E redeemable convertible preferred stock, net of issuance costs		$ 266.8
Temporary equity, issuance costs		$ 0.1

Preferred Stock - Schedule of P

Preferred Stock - Schedule of Preferred Stock (Details) - USD ($) $ / shares in Units, $ in Thousands	Jan. 31, 2022	Jul. 01, 2021	Jan. 31, 2021	Jan. 31, 2020	Jan. 31, 2019
Temporary Equity [Line Items]
Shares Authorized (in shares)	0		168,985,413
Shares Issued (in shares)	0		167,058,113
Shares Outstanding (in shares)	0		167,058,113	113,523,948	97,686,390
Liquidation Amount	$ 0		$ 622,414
Carrying Value	$ 0		$ 621,139	$ 201,826	$ 149,955
Series Seed
Temporary Equity [Line Items]
Shares Authorized (in shares)			10,962,327
Shares Issued (in shares)			10,962,327
Shares Outstanding (in shares)			10,962,327
Liquidation Amount			$ 2,577
Carrying Value			$ 2,553
Original Issuance Price per Share (in USD per share)			$ 0.2351
Series A
Temporary Equity [Line Items]
Shares Authorized (in shares)			12,855,123
Shares Issued (in shares)			12,855,123
Shares Outstanding (in shares)			12,855,123
Liquidation Amount			$ 10,000
Carrying Value			$ 9,948
Original Issuance Price per Share (in USD per share)			$ 0.7779
Series B
Temporary Equity [Line Items]
Shares Authorized (in shares)			20,288,700
Shares Issued (in shares)			20,288,700
Shares Outstanding (in shares)			20,288,700
Liquidation Amount			$ 24,338
Carrying Value			$ 24,241
Original Issuance Price per Share (in USD per share)			$ 1.1996
Series C
Temporary Equity [Line Items]
Shares Authorized (in shares)			40,338,867
Shares Issued (in shares)			40,338,867
Shares Outstanding (in shares)			40,338,867
Liquidation Amount			$ 70,433
Carrying Value			$ 69,845
Original Issuance Price per Share (in USD per share)			$ 1.7460
Series D
Temporary Equity [Line Items]
Shares Authorized (in shares)			29,078,931
Shares Issued (in shares)			29,078,931
Shares Outstanding (in shares)			29,078,931
Liquidation Amount			$ 95,476
Carrying Value			$ 95,239
Original Issuance Price per Share (in USD per share)			$ 3.2833
Series E
Temporary Equity [Line Items]
Shares Authorized (in shares)			31,405,183
Shares Issued (in shares)			31,405,183
Shares Outstanding (in shares)		31,405,183	31,405,183
Liquidation Amount			$ 152,683
Carrying Value			$ 152,539
Original Issuance Price per Share (in USD per share)	$ 4.8617		$ 4.8617
Series F
Temporary Equity [Line Items]
Shares Authorized (in shares)			24,056,282
Shares Issued (in shares)			22,128,982
Shares Outstanding (in shares)			22,128,982
Liquidation Amount			$ 266,907
Carrying Value			$ 266,774
Original Issuance Price per Share (in USD per share)	$ 12.0614		$ 12.0614

Common Stock (Details)

Common Stock (Details)	12 Months Ended
	Jan. 31, 2022vote$ / sharesshares	Jun. 29, 2021shares	Jan. 31, 2021$ / sharesshares
Class of Stock [Line Items]
Common stock, convertibility, percentage of outstanding share holders	6666.67%
Common stock, convertibility, number of years from final prospectus	7 years
Common stock, convertibility, percentage of shares outstanding	25.00%
Common stock, convertibility, death or disability period	12 months
Conversion of redeemable convertible preferred stock (in shares)	0		168,951,059
Exercise of common stock warrants (in shares)	0		954,884
Stock options outstanding (in shares)	42,422,473		37,231,191
Stock options available for future grants (in shares)	38,055,572		5,642,142
Total shares of common stock reserved	88,922,952		212,779,276
RSUs
Class of Stock [Line Items]
Share-based compensation arrangement by share-based payment award, equity instruments other than options, outstanding (in shares)	1,770,304		0
ESPP
Class of Stock [Line Items]
Share-based compensation arrangement by share-based payment award, equity instruments other than options, outstanding (in shares)	6,674,603		0
Total shares of common stock reserved		7,056,319
Class A Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	1,500,000,000		0
Common stock, number of voting rights | vote	1
Common stock, par or stated value per share (in USD per share) | $ / shares	$ 0.0001		$ 0.0001
Class B Common Stock
Class of Stock [Line Items]
Common stock, shares authorized (in shares)	300,000,000		264,659,000
Common stock, number of voting rights | vote	20
Common stock, par or stated value per share (in USD per share) | $ / shares	$ 0.0001		$ 0.0001

Stock-Based Compensation - 2021

Stock-Based Compensation - 2021 Equity Incentive Plan Narrative (Details) - shares	1 Months Ended
	May 31, 2021	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)		88,922,952	212,779,276
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)	35,281,596
Vesting percentage	5.00%

Stock-Based Compensation - Rest

Stock-Based Compensation - Restricted Stock Units (Details) - RSUs	12 Months Ended
	Jan. 31, 2022$ / sharesshares
Number of Shares
Outstanding, beginning of period (in shares)	0
Outstanding, end of period (in shares)	1,770,304
2021 Equity Incentive Plan
Number of Shares
Outstanding, beginning of period (in shares)	0
Granted (in shares)	1,491,253
Released (in shares)	(11,902)
Forfeited (in shares)	(41,998)
Outstanding, end of period (in shares)	1,437,353
Weighted-Average Grant Date Fair Value
Outstanding, beginning of period (in USD per share) | $ / shares	$ 0
Granted (in USD per share) | $ / shares	57.17
Released (in USD per share) | $ / shares	62.60
Forfeited (in USD per share) | $ / shares	54.29
Outstanding, end of period (in USD per share) | $ / shares	$ 57.21

Stock-Based Compensation - Re_2

Stock-Based Compensation - Restricted Stock Units Narrative (Details) - RSUs $ in Millions	12 Months Ended
	Jan. 31, 2022USD ($)
2021 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized amount	$ 77
Cost not yet recognized, period for recognition	3 years 8 months 12 days
2013 Equity Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized amount	$ 6.8
Cost not yet recognized, period for recognition	1 year 7 months 6 days

Stock-Based Compensation - 2013

Stock-Based Compensation - 2013 Equity Incentive Plan Narrative (Details) - 2013 Equity Incentive Plan - USD ($) $ / shares in Units, $ in Millions	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in USD per share)	$ 13.14	$ 1.63	$ 0.43
Vesting of early exercised options	$ 32	$ 5.1	$ 1.5
Options, exercises in period, intrinsic value	333.7	$ 27	$ 1.7
Cost not yet recognized, options, amount	$ 148.6
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expiration period	10 years
Vesting percentage	25.00%
Award vesting period	3 years
Cost not yet recognized, period for recognition	2 years 9 months 18 days

Stock-Based Compensation - Summ

Stock-Based Compensation - Summary Stock Option Plan (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Number of Options
Outstanding, beginning of period (in shares)	37,231,191
Outstanding, end of period (in shares)	42,422,473	37,231,191
2013 Equity Incentive Plan
Number of Options
Outstanding, beginning of period (in shares)	37,231,191
Granted (in shares)	14,048,623
Exercised (in shares)	(8,406,950)
Forfeited (in shares)	(1,131,723)
Outstanding, end of period (in shares)	41,741,141	37,231,191
Expected to vest (in shares)	41,741,141
Options, vested and exercisable, number (in shares)	17,467,223
Weighted-Average Exercise Price
Outstanding, beginning of period (in USD per share)	$ 1.68
Granted (in USD per share)	9.66
Exercised (in USD per share)	1.52
Forfeited (in USD per share)	3.34
Outstanding, end of period (in USD per share)	4.34	$ 1.68
Expected to vest (in USD per shares)	4.34
Options, vested and exercisable, weighted average exercise price (in USD per share)	$ 2.47
Weighted-Average Remaining Contractual Term (in years)
Weighted-Average Remaining Contractual Term (in years), Outstanding	7 years 11 months 12 days	8 years 4 months 2 days
Expected to vest (in years)	7 years 11 months 12 days
Weighted-Average Remaining Contractual Term (in years), Vested and exercisable (in years)	7 years 1 month 28 days
Aggregate Intrinsic Value (in thousands)
Outstanding, beginning of period	$ 442,515
Outstanding, end of period	1,686,738	$ 442,515
Expected to vest	1,686,738
Vested and exerisable	$ 738,584

Stock-Based Compensation - Su_2

Stock-Based Compensation - Summary of Restricted Stock (Details) - RSUs	12 Months Ended
	Jan. 31, 2022$ / sharesshares
Number of Shares
Outstanding, beginning of period (in shares)	0
Outstanding, end of period (in shares)	1,770,304
2013 Equity Incentive Plan
Number of Shares
Outstanding, beginning of period (in shares)	0
Granted (in shares)	346,483
Released (in shares)	(3,316)
Forfeited (in shares)	(10,216)
Outstanding, end of period (in shares)	332,951
Weighted-Average Grant Date Fair Value
Outstanding, beginning of period (in USD per share) | $ / shares	$ 0
Granted (in USD per share) | $ / shares	32.39
Released (in USD per share) | $ / shares	32.69
Forfeited (in USD per share) | $ / shares	32.48
Outstanding, end of period (in USD per share) | $ / shares	$ 32.38

Stock-Based Compensation - Perf

Stock-Based Compensation - Performance Milestone Options Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	1 Months Ended	12 Months Ended
	Feb. 28, 2021	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense		$ 87,889	$ 15,912
Performance Milestone Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	1,243,636
Share-based payment arrangement, expense		$ 12,800
Share-based Payment Arrangement, Tranche One | Performance Milestone Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in USD per share)	$ 10.25
Share-based Payment Arrangement, Tranche Two | Performance Milestone Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in USD per share)	10.37
Share-based Payment Arrangement, Tranche Three | Performance Milestone Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Weighted average grant date fair value (in USD per share)	$ 10.49

Stock-Based Compensation - Mile

Stock-Based Compensation - Milestone Options Narrative (Details) - USD ($) $ in Thousands	1 Months Ended	12 Months Ended
	Mar. 30, 2021	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense		$ 87,889	$ 15,912
Milestone Options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Granted (in shares)	1,404,605
Vesting percentage	100.00%
Share-based payment arrangement, expense		3,100
Cost not yet recognized, amount		$ 16,300
Cost not yet recognized, period for recognition		4 years 7 months 6 days

Stock-Based Compensation - Re_3

Stock-Based Compensation - Restricted Common Stock Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	Feb. 06, 2021	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense		$ 87,889	$ 15,912
Restricted common stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based payment arrangement, expense		10,900
Cost not yet recognized amount		$ 8,700
Cost not yet recognized, period for recognition		1 year
Restricted common stock | Scalyr
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares granted (in shares)	1,315,099
Shares granted, fair value (in USD per share)	$ 14.59
Award vesting period	2 years

Stock-Based Compensation - 2011

Stock-Based Compensation - 2011 Stock Incentive Plan Narrative (Details) - USD ($) $ / shares in Units, $ in Millions	Feb. 06, 2021	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock options outstanding (in shares)		42,422,473	37,231,191
2011 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, outstanding, weighted average exercise price (in USD per share)		$ 1.72
Stock options outstanding (in shares)		681,332
Options, vested and exercisable, number (in shares)		148,499
Options, vested and exercisable, weighted average exercise price (in USD per share)		$ 1.72
Vesting of early exercised options		$ 10.8
Cost not yet recognized, options, amount		$ 4.1
Options exercised (in shares)		1,386,381
Options, exercises in period, intrinsic value		$ 33.4
2011 Stock Incentive Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Cost not yet recognized, period for recognition		1 year 2 months 12 days
Scalyr | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Consideration transferred, equity interests (in shares)	2,138,347
Scalyr | 2011 Stock Incentive Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Options, outstanding, weighted average exercise price (in USD per share)	$ 1.74
Weighted average grant date fair value (in USD per share)	$ 13.10
Scalyr | 2011 Stock Incentive Plan | Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Consideration transferred, equity interests (in shares)	2,138,347

Stock-Based Compensation - Seco

Stock-Based Compensation - Secondary Stock Sales Narrative (Details) - USD ($)	1 Months Ended			3 Months Ended	12 Months Ended
	Jul. 31, 2021	Jun. 30, 2021	May 31, 2021	Jan. 31, 2022	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, consideration received on transaction	$ 1,400,000,000
Share-based payment arrangement, expense					$ 87,889,000	$ 15,912,000
Stock options outstanding
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected dividend yield					$ 0
Private Placement
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, number of shares issued in transaction (in shares)	1,428,568
Private Placement | Common Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, number of shares issued in transaction (in shares)		305,724	85,403
Sale of stock, price per share (in USD per share)			$ 23
Sale of stock, consideration received on transaction		$ 8,700,000	$ 2,000,000
Share-based payment arrangement, expense				$ 0
Private Placement | Common Stock | Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, price per share (in USD per share)		$ 21
Private Placement | Common Stock | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Sale of stock, price per share (in USD per share)		$ 52

Stock-Based Compensation - Assu

Stock-Based Compensation - Assumptions (Details)	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility, minimum	52.30%
Expected volatility, maximum	70.50%
Risk-free interest rate, minimum	0.10%
Risk-free interest rate, maximum	0.30%
Minimum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 months
Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	2 years
Stock options
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected term (in years)	6 years	6 years
Expected volatility, minimum	62.30%	47.30%
Expected volatility, maximum	66.00%	48.70%
Risk-free interest rate, minimum	0.80%	0.40%
Risk-free interest rate, maximum	1.10%	0.60%
Dividend yield	0.00%	0.00%
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Dividend yield	0.00%

Stock-Based Compensation - Comp

Stock-Based Compensation - Components of Stock Based Compensation Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 87,889	$ 15,912
Cost of revenue
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	3,618	308
Research and development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	35,358	6,590
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	15,460	3,835
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Total	$ 33,453	$ 5,179

Stock-Based Compensation - Empl

Stock-Based Compensation - Employee Stock Purchase Plan Narrative (Details) - USD ($) $ / shares in Units, $ in Thousands	Jun. 29, 2021	Jan. 31, 2022	Jan. 31, 2021	Jul. 31, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)		88,922,952	212,779,276
Share price (in USD per share)		$ 35		$ 35
Share-based payment arrangement, expense		$ 87,889	$ 15,912
Value purchased for award		11,400
ESPP
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock, capital shares reserved for future issuance (in shares)	7,056,319
Expiration period	10 years
Percentage of outstanding stock, maximum	1.00%
Consecutive offering period	6 months
Consecutive purchase period	6 months
Maximum employee subscription rate	85.00%
Lookback period	24 months
Share-based payment arrangement, expense		5,500
Amount withheld for future purchases		$ 1,600
Shares purchased for award (in shares)		381,716

Income Taxes - Schedule of Prov

Income Taxes - Schedule of Provision For Income Taxes (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Income Tax Disclosure [Abstract]
Domestic	$ (274,270)	$ (18,159)	$ (1,700)
Foreign	4,173	(98,954)	(74,630)
Loss before provision for income taxes	$ (270,097)	$ (117,113)	$ (76,330)

Income Taxes - Components of In

Income Taxes - Components of Income Tax Expense (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Current:
State	$ 82	$ 62	$ 52
Foreign	1,011	398	185
Total current	1,093	460	237
Deferred:
Foreign	(89)	0	0
Total deferred	(89)	0	0
Total provision for income taxes	$ 1,004	$ 460	$ 237

Income Taxes - Schedule of Effe

Income Taxes - Schedule of Effective Income Tax Rate Reconciliation (Details) - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Income Tax Disclosure [Abstract]
Benefit from income taxes at U.S. federal statutory rate	$ (56,720)	$ (24,594)	$ (16,029)
State taxes, net of federal benefit	82	49	41
Foreign tax rate differential	(1,297)	(1,836)	(6,852)
Stock-based compensation	(23,442)	1,195	771
Non-deductible expenses	322	84	109
Change in valuation allowance	81,739	25,564	22,857
Other	320	(2)	(660)
Total provision for income taxes	$ 1,004	$ 460	$ 237

Income Taxes - Deferred Tax Ass

Income Taxes - Deferred Tax Assets (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021
Deferred tax assets:
Net operating loss carryforwards	$ 174,646	$ 70,735
Research and development expenses	36,989	11,479
Accruals and reserves	18,708	12,986
Operating lease liabilities	11,158	5,416
Stock-based compensation	7,936	140
Other	2,012	532
Gross deferred tax assets	251,449	101,288
Valuation allowance	(218,981)	(86,032)
Total deferred tax assets	32,468	15,256
Deferred tax liabilities:
Acquired intangibles, property and equipment	(6,235)	(1,217)
Deferred contract acquisition costs	(16,722)	(9,697)
Operating lease right-of-use assets	(9,422)	(4,342)
Total deferred tax liabilities	(32,379)	(15,256)
Net deferred tax assets	$ 89	$ 0

Income Taxes - Narrative (Detai

Income Taxes - Narrative (Details) - USD ($)	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Income Tax Disclosure [Abstract]
Valuation allowance	$ (218,981,000)	$ (86,032,000)
Valuation allowance, deferred tax asset, increase (decrease), amount	132,900,000	28,000,000
Deferred tax assets, operating loss carryforwards, domestic	436,800,000
Deferred tax assets, operating loss carryforwards, state and local	268,900,000
Deferred tax assets, operating loss carryforwards, foreign	281,900,000
Deferred tax assets, operating loss carryforwards, subject to expiration	1,100,000
Deferred tax assets, operating loss carryforwards, not subject to expiration	1,100,000
Income tax examination, penalties and interest accrued	$ 0	$ 0

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable To Common Stockholders - Basic and Diluted (Details) - USD ($) $ / shares in Units, $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Numerator:
Net loss	$ (271,101)	$ (117,573)	$ (76,567)
Denominator:
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	174,051,203	35,482,444	32,712,350
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	174,051,203	35,482,444	32,712,350
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share)	$ (1.56)	$ (3.31)	$ (2.34)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share)	$ (1.56)	$ (3.31)	$ (2.34)
Class A and Class B Common Stock
Denominator:
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, basic (in shares)	174,051,203	35,482,444
Weighted-average shares used in computing net loss per share attributable to Class A and Class B common stockholders, diluted (in shares)	174,051,203	35,482,444
Net loss per share attributable to Class A and Class B common stockholders, basic (in USD per share)	$ (1.56)	$ (3.31)
Net loss per share attributable to Class A and Class B common stockholders, diluted (in USD per share)	$ (1.56)	$ (3.31)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable To Common Stockholders - Anti-dilutive Securities Excluded from the Diluted Calculation (Details) - shares	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	46,724,824	207,174,634	141,735,353
Redeemable convertible preferred stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	168,951,059	113,523,948
Stock options
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	42,422,473	37,231,191	26,892,219
Common stock warrants
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	0	954,884	1,276,686
Shares subject to repurchase
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	20,091	37,500	42,500
RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,770,304	0	0
ESPP
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	52,381	0	0
Restricted common stock
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,142,496	0	0
Contingently issuable shares
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Antidilutive securities excluded from computation of earnings per share, amount (in shares)	1,317,079	0	0

Geographic Information - Summar

Geographic Information - Summary of Long-Lived Assets by Geographic Areas (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Jan. 31, 2021
Segment Reporting Information [Line Items]
Total	$ 48,802	$ 31,399
United States
Segment Reporting Information [Line Items]
Total	21,176	10,386
Israel
Segment Reporting Information [Line Items]
Total	26,646	20,987
Rest of world
Segment Reporting Information [Line Items]
Total	$ 980	$ 26

Commitment and Contingencies (D

Commitment and Contingencies (Details) - BlackBerry Litigation	1 Months Ended
	Oct. 31, 2019claimarbitrationlawsuit
Loss Contingencies [Line Items]
Loss contingency, new claims filed, number | claim	9
Loss contingency, number of lawsuits | lawsuit	7
Loss contingency, number of arbitrations | arbitration	2

Employee Benefit Plan (Details)

Employee Benefit Plan (Details) - USD ($)	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021	Jan. 31, 2020
Restructuring Cost and Reserve [Line Items]
Defined contribution plan, cost	$ 0	$ 0	$ 0
Israel
Restructuring Cost and Reserve [Line Items]
Severance costs	$ 3,700,000	$ 2,700,000	$ 1,700,000

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) - Scalyr - USD ($) $ / shares in Units, $ in Thousands	Feb. 06, 2021	Jan. 31, 2022
Business Acquisition [Line Items]
Percentage of voting interests acquired	100.00%
Aggregate consideration transferred	$ 125,300
Cash payments for business acquisition	5,000
Purchase consideration	$ 124,628
Holdback shares (in shares)	1,317,079
Holdback shares, fair value per share (in USD per share)	$ 14.59
Cash related to certain obligations	$ 400
Release term for Holdback Shares and cash	18 months
Business combination, acquisition related costs		$ 1,400
Revenue of acquiree since acquisition date		13,400
Net income of acquiree since acquisition date		$ 200
Noncompete Agreements
Business Acquisition [Line Items]
Finite-lived intangible asset, useful life	3 years
Finite-lived intangible assets, fair value disclosure	$ 700
Common Stock
Business Acquisition [Line Items]
Consideration transferred, equity interests	$ 106,200
Consideration transferred, equity interests (in shares)	7,277,214
Stock options
Business Acquisition [Line Items]
Consideration transferred, equity interests	$ 14,100
Consideration transferred, equity interests (in shares)	2,138,347
Restricted common stock
Business Acquisition [Line Items]
Shares granted (in shares)	1,315,099
Award vesting period	2 years

Acquisitions - Assets Acquired

Acquisitions - Assets Acquired and Liabilities Assumed (Details) - USD ($) $ in Thousands	Jan. 31, 2022	Feb. 06, 2021	Jan. 31, 2021
Business Acquisition [Line Items]
Goodwill	$ 108,193		$ 0
Scalyr
Business Acquisition [Line Items]
Cash and cash equivalents		$ 699
Accounts receivable		3,665
Restricted cash		444
Prepaid expense		277
Intangible assets		17,150
Goodwill		108,193
Accounts payable		(412)
Deferred revenue		(5,041)
Other liabilities		(347)
Total purchase consideration		$ 124,628

Acquisitions - Intangible Asset

Acquisitions - Intangible Assets (Details) - Scalyr $ in Thousands	Feb. 06, 2021USD ($)
Business Acquisition [Line Items]
Fair Value	$ 17,150
Developed technology
Business Acquisition [Line Items]
Fair Value	$ 15,500
Useful Life	7 years
Customer relationships
Business Acquisition [Line Items]
Fair Value	$ 1,500
Useful Life	2 years
Trademarks
Business Acquisition [Line Items]
Fair Value	$ 150
Useful Life	2 years

Acquisitions - Pro Forma (Detai

Acquisitions - Pro Forma (Details) - Scalyr - USD ($) $ in Thousands	12 Months Ended
	Jan. 31, 2022	Jan. 31, 2021
Business Acquisition [Line Items]
Revenue	$ 204,874	$ 101,875
Net loss	$ (262,145)	$ (171,321)

Subsequent Events (Details)

Subsequent Events (Details) - Attivo Networks, Inc - USD ($) $ / shares in Units, $ in Millions	Jul. 31, 2022	Jul. 31, 2022	Mar. 15, 2022
Forecast
Subsequent Event [Line Items]
Business combination, consideration transferred, cash portion, percentage		58.00%
Business combination, consideration transferred, equity portion, percentage		42.00%
Aggregate consideration transferred	$ 616.5
Business acquisition, share price (in USD per share)	$ 40.49	$ 40.49
Business combination, shares, term		30 days
Subsequent Event
Subsequent Event [Line Items]
Percentage of voting interests acquired			100.00%